Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8271674270502292,-2.7177455759348135,0.0,0.0,0.0,8/22,7.46%,NR2F2;ALDH1A2;PTGDS;RBP4;CYP26B1;RBP1;CRABP2;ABCA4
prerank,retinoic acid binding (GO:0001972),-0.7528966954396605,-2.0526695069623138,0.0,0.02454779332701452,0.04,2/12,3.87%,NR2F2;CYP26B1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7719229188208837,-1.9990518911814614,0.007246376811594203,0.03522074694745562,0.079,4/11,11.15%,ITPR1;RASA3;ITPR3;RYR2
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.692179789145264,-1.9779186034339429,0.0,0.027536220340738028,0.103,9/16,11.04%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.692179789145264,-1.9779186034339429,0.0,0.027536220340738028,0.103,9/16,11.04%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5844269381485394,-1.946907374436541,0.0,0.03361980390438945,0.147,9/26,7.81%,SLC6A13;SLC16A12;SLC16A2;ABCG2;SLC16A6;SLC6A12;SLC6A1;SLC16A11;SLC16A4
prerank,monocarboxylic acid binding (GO:0033293),-0.636918075286443,-1.9463912417672515,0.0,0.02881697477519096,0.147,3/18,6.33%,NR2F2;CYP26B1;NAPEPLD
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8723637778364774,1.9132028292147223,0.0,0.029551736761405538,0.022,3/14,0.87%,NOX4;DUOX1;NCF4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.9199469384316408,1.8798813560747374,0.0,0.029551736761405538,0.048,3/10,0.87%,NOX4;DUOX1;NCF4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.7233596446049819,-1.8653635992951734,0.007246376811594203,0.059901952194725654,0.333,7/11,14.13%,ITPR1;TRPC5;ITPR3;TRPC6;TRPC4;TRPC7;TRPC3
prerank,semaphorin receptor activity (GO:0017154),-0.7224443909136309,-1.8577894884733885,0.0,0.057752537923942374,0.358,6/11,8.64%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,CoA-ligase activity (GO:0016405),-0.6678572835488213,-1.8298687752498617,0.004310344827586207,0.0671328782725745,0.428,5/14,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6953813142188796,-1.824376316706674,0.0035087719298245615,0.06413474857374149,0.451,8/12,19.36%,CNOT2;PAN3;CNOT7;NOCT;CNOT6L;TOE1;PNLDC1;CNOT1
prerank,acid-thiol ligase activity (GO:0016878),-0.6753372355347107,-1.8239095172190563,0.008097165991902834,0.0590570100331074,0.453,5/13,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.4614174251624354,-1.8195363444747756,0.0,0.056156155972167,0.46,12/55,4.70%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC16A11;SLC22A4
prerank,store-operated calcium channel activity (GO:0015279),-0.7182301620034585,-1.814985333271237,0.007067137809187279,0.05336476810220548,0.47,6/10,14.13%,TRPC5;TRPC6;TRPC4;ORAI2;TRPC7;TRPC3
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6997403938606783,-1.7645257022174212,0.01048951048951049,0.07826832654990136,0.622,4/11,3.01%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,serine-type peptidase activity (GO:0008236),0.6203361865996974,1.7295887585242724,0.0,0.40781396730739644,0.645,23/96,16.64%,HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;GZMK;PRSS12;PCSK4;RHBDF1;TPP1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;PRSS8;HGF;HTRA2
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7402264723821945,1.7279416410840815,0.0,0.31546478992800414,0.659,4/21,2.88%,FGF18;FGF7;NPTN;FGF2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6668645137226146,-1.7164445081508428,0.017985611510791366,0.1081970673272216,0.765,4/11,14.90%,PPP1R1A;PPP1R8;PPP1R14A;PABIR1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.8213370342818493,1.706600380443457,0.005284015852047556,0.3554088874505039,0.754,5/12,7.26%,ARSA;SULF2;ARSJ;ARSI;SULF1
prerank,protease binding (GO:0002020),0.6086533173642217,1.7040221633499608,0.0020429009193054137,0.30487541758850045,0.766,24/99,10.48%,COMP;COL3A1;COL1A2;TIMP2;COL1A1;CCBE1;DPP4;FAP;CD177;ITGB3;ANXA2;ECM1;SRI;BIN1;SPATA2;SYVN1;ADAMTSL4;ATP9A;CARD16;TRIP4;CLTC;ADRM1;ITGAV;CSTB
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6100041636005828,-1.689534934693693,0.026923076923076925,0.12455964695855962,0.842,4/13,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,platelet-derived growth factor binding (GO:0048407),0.816363146886778,1.6806934623196137,0.00823045267489712,0.3648935877253551,0.858,6/11,10.13%,COL3A1;COL1A2;COL1A1;COL5A1;COL6A1;COL2A1
prerank,serine-type endopeptidase activity (GO:0004252),0.6061951456930957,1.6653055081737258,0.0,0.38823594170296527,0.91,19/80,16.64%,PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;PRSS12;PCSK4;RHBDF1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;HGF;HTRA2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6517976929706842,-1.6555946275014892,0.014285714285714285,0.15125947047636243,0.907,6/10,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5611363691435302,-1.6555919232970289,0.030973451327433628,0.1432984457144486,0.907,6/16,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.5550203501463419,-1.641180372799635,0.011627906976744186,0.14856751439654006,0.927,10/16,33.14%,ETHE1;CDO1;ALOX12;ADI1;PIR;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,BMP receptor binding (GO:0070700),-0.6100053852804186,-1.633808060099354,0.048507462686567165,0.1489639383881564,0.934,4/12,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,microtubule plus-end binding (GO:0051010),0.7006618026472353,1.6264993231640283,0.013836477987421384,0.5555726511144241,0.979,13/20,22.51%,DCTN1;CLIP1;DST;MAPRE3;CLIP2;MAPRE1;CLIP4;PAFAH1B1;STIM1;CLIP3;CLASP2;NUMA1;FBXW11
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6864210524812338,1.5684697078663539,0.0163727959697733,0.9481182210950944,1.0,7/19,12.37%,EFNA5;ANGPT4;DGKQ;GAS6;ABI1;NRG3;EGF
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.7146738077042532,1.5563858517051303,0.033854166666666664,0.9754759652787591,1.0,4/14,10.95%,CAPN5;CAPN2;CAPN1;CAPN11
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5387061416272275,-1.5493610233381392,0.06557377049180328,0.2442650976314587,0.988,5/15,9.80%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,calcium-release channel activity (GO:0015278),-0.5289562362584951,-1.533955476893348,0.05909090909090909,0.2560116744520588,0.995,3/17,5.14%,ITPR1;RASA3;ITPR3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.7274856012984672,1.5320673983935653,0.028,1.0,1.0,2/13,3.53%,EHHADH;MIF
prerank,phospholipase binding (GO:0043274),0.7117583638395939,1.5261506576585175,0.036827195467422094,1.0,1.0,4/13,6.81%,SYK;FYN;DGKQ;SRC
prerank,clathrin adaptor activity (GO:0035615),0.6927486970181297,1.5244401097543272,0.029609690444145357,1.0,1.0,4/15,6.08%,STON2;AP1G2;AP1M1;AP2A2
prerank,protein kinase C binding (GO:0005080),0.5911427364892757,1.5152725796988002,0.020134228187919462,1.0,1.0,15/43,10.44%,AVPR1A;NELL2;IRS1;DACT3;ADAM9;HDAC9;HDAC7;DACT1;DACT2;YWHAG;PRKD2;PARD6A;TIRAP;ITGAV;SQSTM1
prerank,filamin binding (GO:0031005),-0.6146753453114671,-1.5091540063309967,0.06642066420664207,0.2818549168598153,1.0,6/11,15.73%,NEBL;SYNPO2;TMEM67;CEACAM1;FBLIM1;MICALL2
prerank,frizzled binding (GO:0005109),0.5994169687498538,1.486055884920455,0.03244495944380069,1.0,1.0,6/34,2.82%,MYOC;LRP6;WNT10B;WNT2;CCDC88C;WNT9A
prerank,bHLH transcription factor binding (GO:0043425),-0.4884376390642662,-1.479895084492424,0.05194805194805195,0.3180540178891446,1.0,8/19,12.63%,FHL2;SMAD3;CREBBP;SP1;TCF12;SIRT1;LMO2;USF1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5554464717230042,-1.4769263950573333,0.07434944237918216,0.31103449839262376,1.0,6/11,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5502322793422533,-1.4750361763043063,0.08270676691729323,0.30307235336267363,1.0,5/13,9.80%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,phospholipase inhibitor activity (GO:0004859),0.7186397034920937,1.472631344895784,0.05539358600583091,1.0,1.0,3/10,2.53%,SNCB;ANXA1;ANXA2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7167524155563938,1.4691301407613286,0.06371191135734072,1.0,1.0,3/10,6.10%,DPP4;FAP;PRCP
prerank,C-C chemokine binding (GO:0019957),0.6252582973316626,1.4650251509151966,0.05084745762711865,1.0,1.0,6/22,17.61%,ACKR3;ACKR4;ACKR1;ZFP36;CXCR4;CXCR2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6601074194394897,1.4595651643828957,0.06919945725915876,1.0,1.0,3/15,4.54%,SLC1A5;SLC1A7;SLC1A6
prerank,ligand-gated calcium channel activity (GO:0099604),-0.47711121894745023,-1.4356167737238517,0.07906976744186046,0.36181312773295315,1.0,3/19,5.14%,ITPR1;RASA3;ITPR3
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.3790227112417982,-1.4337105785328428,0.04716981132075472,0.3524650924929806,1.0,15/47,13.35%,SLC7A11;SLC7A2;SLC6A13;SLC16A2;PDPN;SLC6A1;SLC38A11;SLC7A5;SLC22A4;SLC3A2;SLC38A5;SLC25A44;SLC6A6;SLC43A1;SLC7A14
prerank,growth factor receptor binding (GO:0070851),0.5178187812858367,1.4270175059597026,0.017616580310880828,1.0,1.0,27/95,16.67%,AREG;FGF18;FGF7;TIMM50;GLMN;BTC;FYN;ITGB3;VEGFA;FGF2;ITGA5;PTPRJ;ARF4;SRC;TLR5;SNX1;ESM1;ATXN2;PSEN1;ERN1;PIBF1;EGF;PDGFRA;FER;IL4;IL6;EFEMP1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.654514950604469,1.4235659440208523,0.08015768725361366,1.0,1.0,1/14,0.74%,DHRS9
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5895123087580199,-1.4232868403947485,0.11564625850340136,0.3587535476950933,1.0,3/10,3.01%,SLC6A13;SLC6A12;SLC6A1
prerank,tropomyosin binding (GO:0005523),-0.488076992193088,-1.4222319650164454,0.08962264150943396,0.3487301523272512,1.0,3/16,6.57%,NEBL;CALD1;TMOD3
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6856913703866255,1.4200923975140147,0.08628005657708628,1.0,1.0,3/11,14.44%,AKR1B1;RDH14;RDH13
prerank,acylglycerol lipase activity (GO:0047372),0.6978475375431481,1.4190245323522248,0.07832167832167833,1.0,1.0,1/11,0.62%,MGLL
prerank,lipoprotein particle binding (GO:0071813),-0.45663093952333683,-1.415787380009132,0.08021390374331551,0.348672053587785,1.0,6/20,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,3'-5' DNA helicase activity (GO:0043138),0.6547197858124874,1.4152738318757396,0.07197943444730077,1.0,1.0,6/16,18.32%,NAV2;HELQ;ASCC3;ERCC3;RECQL;BLM
prerank,receptor antagonist activity (GO:0048019),0.6248341908882437,1.4111360273555198,0.09090909090909091,1.0,1.0,4/17,17.98%,DKK2;IGSF1;DKK3;PXDN
prerank,ferrous iron binding (GO:0008198),-0.4660604140108587,-1.405901515696107,0.056768558951965066,0.3548595367378173,1.0,17/21,35.26%,SNCA;FTH1;PHYH;EGLN3;FECH;EGLN1;ISCU;CDO1;FTL;FTO;ALKBH2;TET2;ACP5;ALKBH3;HAAO;HIF1AN;HEPH
prerank,phospholipase activator activity (GO:0016004),0.6908372292557979,1.403676975403449,0.08071748878923767,1.0,1.0,4/10,9.18%,CCL8;FYN;SRC;STX4
prerank,water transmembrane transporter activity (GO:0005372),-0.5464821593280289,-1.397608015615913,0.09121621621621621,0.3577636835651975,1.0,2/11,8.86%,PDPN;AQP11
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5196757791789688,1.3968415941159025,0.046511627906976744,1.0,1.0,13/70,10.58%,HAS2;HAS1;B4GALT1;B3GALNT1;CSGALNACT2;EXT1;B4GALNT4;POMGNT2;CHSY3;B3GAT3;RFNG;LARGE1;B3GNT8
prerank,growth factor activity (GO:0008083),0.5063214281318464,1.3953839815733518,0.03664921465968586,1.0,1.0,17/74,16.31%,LIF;AREG;FGF18;FGF7;BTC;VEGFA;FGF2;CLCF1;INHA;JAG1;NRG3;EGF;GDNF;ARTN;IL4;IL6;HGF
prerank,metalloendopeptidase activity (GO:0004222),0.5019699871981781,1.3929491317506237,0.038662486938349006,1.0,1.0,23/76,18.45%,ADAMTS5;ADAMTS2;MMP2;ADAM9;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;EEF1AKMT4-ECE2;ECE2;PAPLN;THOP1;RCE1;IDE;SPG7;MMP16;ADAMTS6
prerank,chemokine binding (GO:0019956),0.569549455980156,1.3922264803103253,0.08208092485549133,1.0,1.0,9/30,17.61%,ACKR3;ITGB3;FGF2;ACKR4;ITGAV;ACKR1;ZFP36;CXCR4;CXCR2
prerank,lipase activator activity (GO:0060229),0.6776602558593992,1.3912702139364583,0.10428571428571429,1.0,1.0,3/10,6.81%,CCL8;FYN;SRC
prerank,glucuronosyltransferase activity (GO:0015020),0.6102936308349154,1.388901618610201,0.10050251256281408,1.0,1.0,5/19,21.54%,EXT1;B3GAT3;LARGE1;CHPF;B3GAT2
prerank,ATPase binding (GO:0051117),0.5065081987586025,1.3861836844438453,0.05620360551431601,1.0,1.0,22/71,17.22%,AR;ESR1;EGFR;ANK2;ATP6V0A2;TOR1AIP2;SYVN1;ZNHIT6;SRC;ABCA1;PKD2;PSEN1;ATP6V1E1;PDE4D;BBC3;SNU13;PPP3CA;CLPP;ATP6V0A1;SELENOS;ANK1;NUFIP1
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5496433171494457,1.3834911027069954,0.08265424912689173,1.0,1.0,8/35,7.45%,SYK;SRMS;TNK1;FYN;CLK1;CSK;SRC;ABL2
prerank,ubiquitin-specific protease binding (GO:1990381),0.6105626755759993,1.3830282940261849,0.08756345177664974,1.0,1.0,9/19,24.39%,SPATA2;SYVN1;CLTC;AMFR;SELENOS;PTEN;DERL1;RHBDD2;LCOR
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6836256837607291,1.3824064246930408,0.10540915395284327,1.0,1.0,5/11,13.02%,SLC5A9;SLC17A5;SLC2A10;SLC23A1;SLC23A2
prerank,cardiolipin binding (GO:1901612),0.6830367140313297,1.3770604218549949,0.10099573257467995,1.0,1.0,1/10,0.56%,UCP1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.497222815103221,1.3755003761295816,0.048370136698212406,1.0,1.0,25/83,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,solute:sodium symporter activity (GO:0015370),0.571932563116085,1.3747443431847497,0.07790697674418605,1.0,1.0,3/27,2.11%,SLC5A9;SLC4A10;SLC4A8
prerank,lipase activity (GO:0016298),0.5341535356694411,1.3632298727831462,0.06981981981981981,1.0,1.0,10/43,19.36%,MGLL;SMPD3;CEL;LCAT;SEC23IP;PNPLA8;DAGLB;LIPC;LIPH;DDHD1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.561469224816283,1.3600632243331399,0.1070559610705596,1.0,1.0,7/25,11.05%,PARP3;ART4;PARP11;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,chemoattractant activity (GO:0042056),0.5643050568047862,1.356778625136963,0.11057108140947752,1.0,1.0,8/26,16.31%,FGF7;VEGFA;FGF2;MIF;CXCL10;GPNMB;GDNF;HGF
prerank,cytokine activity (GO:0005125),0.47958600892118897,1.3559312797732581,0.02233502538071066,1.0,1.0,18/131,6.74%,LIF;CCL8;WNT10B;WNT2;TGFB3;IL16;CTF1;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;CLCF1;IL33;CXCL10;TNFRSF11B;INHA
prerank,metallopeptidase activity (GO:0008237),0.4760936485312633,1.3509941890957562,0.036585365853658534,1.0,1.0,32/113,18.45%,ADAMTS5;BMP1;ADAMTS2;ANPEP;MMP2;ADAM9;ADAMTS3;COPS5;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;LNPEP;DPEP1;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;EEF1AKMT4-ECE2;ECE2;NUDT16;PAPLN;THOP1;ADAM15;RCE1;IDE;SPG7;LAP3;MMP16;METAP2;ADAMTS6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6690686552422335,1.3507520257270618,0.13150684931506848,1.0,1.0,2/10,7.87%,AMDHD1;DPEP1
prerank,anion transmembrane transporter activity (GO:0008509),-0.51422775043635,-1.349935019869337,0.1267605633802817,0.43344389360271357,1.0,4/12,4.49%,ABCG2;SLCO2B1;SLC39A8;SLC22A6
prerank,galactosyltransferase activity (GO:0008378),0.656287018136776,1.34941831682334,0.12583668005354753,1.0,1.0,2/11,2.22%,B4GALT3;B4GALT1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6339049826810941,1.3482067537083486,0.11171662125340599,1.0,1.0,3/13,10.24%,GPSM2;GPSM1;GDI1
prerank,LRR domain binding (GO:0030275),-0.48594384244110067,-1.3480320419680216,0.14173228346456693,0.42445743606626435,1.0,2/14,0.31%,PAWR;ROBO1
prerank,cytokine receptor binding (GO:0005126),0.4912048100649798,1.3454160124478887,0.06263048016701461,1.0,1.0,10/83,6.96%,TNFSF9;SYK;LIF;TIMM50;VEGFA;TGFB2;MIF;CLCF1;SOCS2;TLR5
prerank,C-C chemokine receptor activity (GO:0016493),0.5802866917036511,1.3392310139712356,0.11814859926918392,1.0,1.0,4/21,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5425805290492955,1.3343741364476174,0.12778429073856976,1.0,1.0,4/29,4.54%,SLC1A5;SLC25A21;SLC26A5;SLC1A6
prerank,hormone activity (GO:0005179),0.5024525317410073,1.3340437386326707,0.0859375,1.0,1.0,9/54,13.44%,AMH;METRNL;INHA;GRP;ADCYAP1;SPX;CCL25;HCRT;TRH
prerank,O-acyltransferase activity (GO:0008374),0.5419168368222993,1.333775791104614,0.11137162954279015,1.0,1.0,11/30,20.99%,GPAT4;MOGAT1;PLAAT1;LCAT;LPCAT1;MBOAT7;MOGAT2;PIGW;GPAT3;GPAM;SOAT1
prerank,deubiquitinase activity (GO:0101005),0.4767432053331712,1.327257935279559,0.06347554630593132,1.0,1.0,25/88,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,pre-mRNA binding (GO:0036002),0.5433494939310097,1.3252190728238438,0.11004784688995216,1.0,1.0,11/28,19.98%,TARBP2;HNRNPA1;SRSF6;RBM4;U2AF1;RBM22;CELF2;DDX5;SLBP;U2AF2;PTBP1
prerank,omega peptidase activity (GO:0008242),0.47522038641384523,1.320312333431923,0.07090719499478623,1.0,1.0,26/89,16.13%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;GGT7;STAMBPL1;USP7;MINDY3;USP22
prerank,calcium-activated potassium channel activity (GO:0015269),0.6302757251874925,1.3161401338909675,0.14305177111716622,1.0,1.0,2/11,5.97%,KCNMA1;KCNU1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.3942466042933539,-1.314699454223082,0.11392405063291139,0.47985022561091245,1.0,8/26,14.90%,PTN;PPP1R1A;LMTK2;BOD1L1;PPP1R8;PPME1;PPP1R14A;PABIR1
prerank,transcription coactivator binding (GO:0001223),0.5642219074964163,1.3142465314581555,0.1391304347826087,1.0,1.0,4/20,8.96%,AR;ESR1;SMAD4;CDK9
prerank,adrenergic receptor binding (GO:0031690),0.5873787457867676,1.3114459910755891,0.14732724902216426,1.0,1.0,6/16,11.84%,GNAS;UCHL1;DLG4;C1QBP;MAGI2;PDE4D
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5442370847061386,1.3082614422799284,0.1403091557669441,1.0,1.0,6/25,11.98%,FMO4;FMO2;FMO1;CYP27B1;MICAL2;POR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5238177747342796,-1.30655277059503,0.17747440273037543,0.4837375794864658,1.0,3/10,5.56%,PRKAG2;PKIG;PRKAR1B
prerank,microtubule binding (GO:0008017),0.45309544327320883,1.3032587866061316,0.021042084168336674,1.0,1.0,75/222,22.87%,MID1;NME8;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;CEP295NL;FGF13;S100A8;S100A9;HOOK2;CLIP1;MID2;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;POLB;ALMS1;MAPRE1;CLIP4;CAMSAP1;MAPT;KIF20B;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;UXT;NAV3;PAFAH1B1;STIM1;CLIP3;MDM1;RMDN2;KIF26B;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;FBXW11;MAP1S;CCDC88A;RMDN1
prerank,hexosyltransferase activity (GO:0016758),0.4717377591104444,1.2948238029034511,0.07723995880535531,1.0,1.0,20/101,11.50%,HAS2;HAS1;B4GALT3;B4GALT1;B3GALNT1;CSGALNACT2;FUT2;DPY19L2;EXT1;B4GALNT4;POMGNT2;PIGZ;CHSY3;B3GAT3;RFNG;ALG1;LARGE1;FUT9;B3GNT8;GBA2
prerank,endopeptidase activity (GO:0004175),0.4459188517760837,1.2921547998138132,0.01903807615230461,1.0,1.0,54/257,16.91%,ADAMTS5;HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;UCHL1;FAP;PCSK5;ADAMTS2;MMP2;ADAM9;PRSS12;USP36;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;PCSK4;ADAMTSL4;RHBDF1;USP10;USP29;TPP1;MMP11;ADAMTSL5;PSEN1;ECE1;MASP2;ADAMTSL3;ADAMTS18;USP26;USP33;GZMM;EEF1AKMT4-ECE2;ECE2;USP48;NAPSA;PAPLN;PIK3IP1;USP5;THOP1;KLK1;KLK6;RCE1;TASP1;USP7;CLPP;PDIA3;HGF;HTRA2;IDE;SPG7
prerank,peptidoglycan binding (GO:0042834),-0.5359850041941976,-1.2920356591910511,0.18796992481203006,0.5023403504020942,1.0,7/10,35.83%,RNASE7;NOD1;NOD2;PGLYRP1;JCHAIN;NLRP3;TLR2
prerank,metallocarboxypeptidase activity (GO:0004181),-0.41007843790042253,-1.2868672433174326,0.12716763005780346,0.5005615247986874,1.0,4/26,5.65%,AEBP1;CPE;CPM;AGBL3
prerank,single-stranded telomeric DNA binding (GO:0043047),0.6252649485709826,1.2867017499447995,0.17372881355932204,1.0,1.0,5/11,22.09%,HNRNPA1;CTC1;TERF1;RAD50;TERF2IP
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5636956400050623,1.2866598030481333,0.18261964735516373,1.0,1.0,3/18,2.53%,ANXA1;PKP3;ANXA2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3445297519382544,-1.2801592639691488,0.1111111111111111,0.5021754836388517,1.0,9/48,8.81%,TRPM3;TRPM6;SLC12A7;NALCN;SLC41A1;SLC12A2;ABCC9;TRPC6;CALHM5
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5356774919797469,1.2763433399461406,0.17515527950310558,1.0,1.0,4/24,5.66%,CAMKK1;EEF2K;CAMK2D;PHKA2
prerank,ribosome binding (GO:0043022),0.4891387933830361,1.2731823839541245,0.12472160356347439,1.0,1.0,14/46,18.02%,RPSA;IGHMBP2;C1QBP;SRP19;GTPBP6;MRPS27;EIF6;SBDS;EIF2S1;ZC3H12A;SEC61A1;CPEB1;YTHDF1;NAA15
prerank,pentosyltransferase activity (GO:0016763),0.49880465479607994,1.271499258374471,0.1716937354988399,1.0,1.0,9/36,11.05%,PARP3;UMPS;ART4;PARP11;PARP6;SIRT2;LARGE1;ZC3HAV1;PARP14
prerank,1-phosphatidylinositol binding (GO:0005545),0.5813297346263073,1.2709232041310217,0.21373056994818654,1.0,1.0,4/15,11.33%,SESTD1;SCIN;FRMPD2;WDFY1
prerank,kinase inhibitor activity (GO:0019210),0.513279022773838,1.2696645890657758,0.16055045871559634,1.0,1.0,14/33,25.02%,LRP6;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;DUS2;YWHAB;HEXIM1;DNAJC3
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.31110334645546567,-1.2692692396473777,0.05970149253731343,0.5127591860791915,1.0,22/71,13.46%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PTPRD;PTPN9;PTPRM;PTPRN2;PALD1;PTPRZ1;PTPRO;PTPN1;CDC25A;PTPRT;PTPN2;HACD2;PTPN4;PTPN21;PTP4A2;PTPRN;UBASH3B
prerank,myosin V binding (GO:0031489),0.5765654214073002,1.2667260508317881,0.18276762402088773,1.0,1.0,7/15,26.09%,RAB6A;RAB6B;RAB3D;RAB27B;RAB10;RAB39B;RAB3C
prerank,calcium ion binding (GO:0005509),0.4356378482123773,1.2659175983650461,0.014,1.0,1.0,40/323,8.22%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;SYT2;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A8;S100A9;SMOC2;SLIT1;SYT12;SYT11;CALU;DSC3;DSC2;COLEC11;SYT13;RCN3;THBS4;RET;PKD2;S100A6;CAPN1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5064752826424166,1.263425170063955,0.1691948658109685,1.0,1.0,10/33,17.52%,AR;SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;LLPH;UVSSA;ERCC5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45625090781911315,1.2633755724759057,0.12750263435194942,1.0,1.0,17/72,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;TIRAP;TWF1;PLEKHA4;SNX21;AVIL;SLC9A1
prerank,myosin II binding (GO:0045159),0.6322091101418292,1.262903862487446,0.17887323943661973,1.0,1.0,2/10,3.65%,GSN;LLGL1
prerank,gap junction channel activity (GO:0005243),-0.4120140421126447,-1.2624584481511845,0.16574585635359115,0.515528480689678,1.0,10/22,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,general transcription initiation factor binding (GO:0140296),0.5260302683897033,1.2623274495258614,0.19174757281553398,1.0,1.0,6/25,15.51%,AR;ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,neuropeptide hormone activity (GO:0005184),0.53604886947167,1.2607911755491954,0.1828358208955224,1.0,1.0,4/22,12.23%,GRP;ADCYAP1;SPX;HCRT
prerank,receptor ligand activity (GO:0048018),0.43541234591541805,1.260628504407069,0.025,1.0,1.0,32/245,9.59%,LIF;SEMA3C;AREG;AMH;FGF18;WNT10B;FGF7;DPP4;WNT2;TGFB3;IL16;CTF1;BTC;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;METRNL;CLCF1;IL33;CXCL10;TNFRSF11B;INHA;GAS6;SEMA3A;JAG1;TNFSF13B;CCL25;NRG3;BMP8A
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5402307587234005,1.2598903106335684,0.1826086956521739,1.0,1.0,9/21,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6300173680006784,1.258652193940643,0.20084865629420084,1.0,1.0,5/10,21.47%,GNAS;DLG4;SQSTM1;NSF;SHISA6
prerank,carboxypeptidase activity (GO:0004180),-0.35586531086694173,-1.2546714165238346,0.125,0.5193604771983279,1.0,5/35,5.65%,AEBP1;CPE;CPM;MINDY2;AGBL3
prerank,ribonuclease P activity (GO:0004526),0.6047355030302015,1.2518242067349086,0.2273972602739726,1.0,1.0,3/11,5.83%,RPP25;RPP21;PRORP
prerank,G protein-coupled receptor binding (GO:0001664),0.44141041043525947,1.2491589179224054,0.07951070336391437,1.0,1.0,18/132,10.16%,MYOC;LRP6;WNT10B;GNAS;WNT2;GNAI3;CCDC88C;WNT9A;USP4;C1QBP;BICD1;S1PR2;STUB1;FZD7;CCL25;GNAZ;USP33;CALCA
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6154548628644593,1.2484843862429442,0.24415204678362573,1.0,1.0,2/10,7.64%,EHHADH;AUH
prerank,chemokine receptor activity (GO:0004950),0.5275778071709238,1.2459713400119703,0.19636363636363635,1.0,1.0,4/24,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,wide pore channel activity (GO:0022829),-0.40444266468081297,-1.244636213608851,0.13966480446927373,0.5288567107302122,1.0,10/23,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,heme binding (GO:0020037),0.4594678708202199,1.2429280216928902,0.15828877005347594,1.0,1.0,5/65,6.81%,NOX4;CYP2S1;NR1D1;DGCR8;SRC
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5532473363358925,1.2409479854215006,0.22150259067357514,1.0,1.0,3/18,15.10%,DHRS9;HSD3B7;HSD17B8
prerank,nuclear import signal receptor activity (GO:0061608),0.572118898721,1.2401501420310481,0.21156373193166886,1.0,1.0,9/15,26.59%,KPNA2;IPO9;TNPO2;IPO5;KPNA1;RANBP6;TNPO1;KPNA6;KPNB1
prerank,ligand-gated channel activity (GO:0022834),0.506604288319748,1.2394228273378904,0.20023696682464456,1.0,1.0,13/29,27.38%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,O-methyltransferase activity (GO:0008171),0.6107223318069724,1.2390663054648445,0.22284908321579688,1.0,1.0,7/10,29.90%,MEPCE;COQ3;COMT;CMTR2;FTSJ3;ASMT;LRTOMT
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5129345771837514,-1.2374892971902491,0.1970260223048327,0.5329748209025053,1.0,4/10,12.85%,SLC24A3;SLC8A3;SLC3A2;SLC24A5
prerank,dynactin binding (GO:0034452),0.5953879621965302,1.2363681888004496,0.21031207598371776,1.0,1.0,5/12,18.96%,BICD1;MAPT;BBS4;SNX6;PAFAH1B1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6167972313060434,1.233445310432167,0.23976608187134502,1.0,1.0,4/10,25.79%,DESI2;STAMBPL1;CYLD;OTUD4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.43938744951691405,-1.2330507991392028,0.20357142857142857,0.5306274622315895,1.0,2/14,0.45%,SLC7A11;SLC1A3
prerank,cAMP binding (GO:0030552),-0.47520818614353916,-1.2321561589931558,0.21561338289962825,0.5216406081990586,1.0,2/11,0.58%,RAPGEF4;RAPGEF2
prerank,ligand-gated ion channel activity (GO:0015276),0.502772627018206,1.2298855227806718,0.20286396181384247,1.0,1.0,13/30,27.38%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.47840156893206415,1.2274142920525621,0.19866814650388456,1.0,1.0,11/42,13.54%,ANXA1;PKP3;NPTN;ANXA2;JAM3;CD47;SIRPA;DSCAM;PDLIM1;IGSF9;PALLD
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5425209733398386,1.226351669883063,0.2608695652173913,1.0,1.0,8/17,24.46%,GRIN3A;GRIN2D;GRIA2;GRIN2A;GRIA3;GRIK5;GRIK2;GRIK4
prerank,translation initiation factor activity (GO:0003743),0.4862289557724026,1.2247480249310392,0.19402985074626866,1.0,1.0,19/36,27.14%,EIF3B;COPS5;EIF4A1;EIF3K;AGO2;EIF1;EIF3A;EIF2S1;EIF3E;EIF3D;EIF2S2;EIF2B1;EIF2A;EIF4G3;EIF3L;EIF2B2;EIF4G1;EIF4E2;EIF3M
prerank,cAMP response element binding (GO:0035497),0.5957642869805228,1.2234472964673953,0.2548435171385991,1.0,1.0,5/10,21.89%,CREB5;CREB3L1;ATF7;E4F1;JUN
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4354592456941434,1.2206354270401965,0.15113871635610765,1.0,1.0,21/91,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;CLVS2;TIRAP;WIPI2;TWF1;PLEKHA4;WDR45B;SNX21;AVIL;MAPT;SLC9A1
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4565572205440911,-1.220264312466342,0.1909722222222222,0.5366099701901772,1.0,3/12,12.51%,SLC3A2;SLC38A5;SLC6A6
prerank,tubulin binding (GO:0015631),0.4232271385368406,1.2202242277002344,0.041082164328657314,1.0,1.0,103/295,25.85%,MID1;NME8;RAB11FIP5;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;FYN;CEP295NL;FGF13;S100A8;S100A9;HOOK2;ATF5;CLIP1;MID2;GPAA1;DLEC1;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;NCALD;POLB;ALMS1;CAMSAP1;MAPT;TBCEL;KIF20B;SETD2;TPPP3;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;BBS4;INO80;BCAS3;BLOC1S2;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;ALDOA;UXT;NAV3;PAFAH1B1;CLIP3;MDM1;RMDN2;STMN4;KIF26B;TTLL11;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;MAP1S;DNAL1;CCDC88A;TPR;RMDN1;TRIM36;NLRP5;KATNA1;EMD;RMDN3;ARL8A;MTCL1;VBP1;AGBL1;PHF6;KIF13B;EML6;CCDC88B;TPGS1
prerank,protein tyrosine kinase activity (GO:0004713),0.43555473116666027,1.2187381193911557,0.13641025641025642,1.0,1.0,28/108,14.52%,SYK;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;CLK1;CSK;RET;SRC;ABL2;TWF1;EPHB3;DYRK2;MUSK;CAMKK2;EPHA10;SCYL1;FLT3;HIPK4;PDGFRA;FER;DDR1
prerank,chemokine receptor binding (GO:0042379),0.4834996446392303,1.2165999525412132,0.21412037037037038,1.0,1.0,5/35,12.90%,CCL8;ITCH;CXCL10;CCL25;CCL13
prerank,phospholipase activity (GO:0004620),0.4503237875037885,1.2136445003467298,0.1700105596620908,1.0,1.0,15/67,20.37%,MGLL;SMPD3;PLCE1;PLCB4;PLAAT1;SEC23IP;PNPLA8;PLA2G4E;PDIA3;SMPD1;LIPC;LIPH;DDHD1;GPLD1;GDPD3
prerank,gated channel activity (GO:0022836),0.5667152032450058,1.2124713792981932,0.22,1.0,1.0,3/14,7.21%,PIEZO2;TMEM63A;TMEM266
prerank,syntaxin-1 binding (GO:0017075),-0.3773295468202946,-1.2120789402277499,0.18627450980392157,0.5442139051062914,1.0,5/22,8.74%,UNC13B;UNC13C;SYNPR;STXBP5;DAPK1
prerank,glucose transmembrane transporter activity (GO:0005355),0.5460123911861008,1.2105053634601142,0.24525916561314792,1.0,1.0,4/17,14.46%,SLC5A9;MFSD4A;SLC2A10;SLC2A3
prerank,ribosomal large subunit binding (GO:0043023),0.5751969618399461,1.2063276224542023,0.2363150867823765,1.0,1.0,6/11,14.08%,DHX33;CPSF6;NPM1;EIF6;LTN1;RBM3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.5701979514640914,1.206028506698816,0.2532981530343008,1.0,1.0,6/13,14.13%,ITGB3;VEGFA;ITGA5;PTPRJ;ERN1;PDGFRA
prerank,chloride transmembrane transporter activity (GO:0015108),0.5473515039991654,1.2038650979467342,0.2693298969072165,1.0,1.0,5/16,17.09%,SLC26A5;SLC4A8;SLC26A6;SLC12A5;SLC26A1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4562830304142128,1.2007736949743233,0.210989010989011,1.0,1.0,7/49,5.23%,ANXA1;SYT2;ANXA2;CPNE8;SYT12;SYT11;SYT13
prerank,exopeptidase activity (GO:0008238),0.4584625923404139,1.1979126568968494,0.2108167770419426,1.0,1.0,22/50,26.90%,DPP4;FAP;ANPEP;PRCP;LNPEP;DPEP1;CNDP2;XPNPEP3;NUDT16;NPEPPS;RCE1;LAP3;METAP2;DPP9;METAP1;METAP1D;JMJD7;ZMPSTE24;DPEP2;DPP10;CTSA;DPP7
prerank,glutamate receptor binding (GO:0035254),0.5327801592054592,1.1969791379623584,0.2537128712871287,1.0,1.0,5/17,15.86%,GNAS;DLG4;SQSTM1;SYNDIG1;NSF
prerank,nucleotide diphosphatase activity (GO:0004551),-0.426095848694706,-1.195871947721301,0.24354243542435425,0.5704379799725164,1.0,6/14,15.83%,ENPP1;NUDT4;ENPP4;NUDT3;NUDT12;NUDT13
prerank,androgen receptor binding (GO:0050681),0.4998892915667516,1.1953172786697905,0.23886138613861385,1.0,1.0,15/25,30.27%,FOXP1;PRMT2;SMARCA4;RNF14;TRIM68;DDX5;NSD1;TMF1;RNF6;KDM4C;CALR;KDM3A;PRPF6;ZBTB7A;WIPI1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.51510333428317,1.1923350566865458,0.25156445556946183,1.0,1.0,7/20,15.12%,GPAT4;MOGAT1;AGPAT3;LPCAT1;MOGAT2;AGPAT5;GPAT3
prerank,CoA hydrolase activity (GO:0016289),0.5363324415720765,1.1915226655546884,0.27320261437908494,1.0,1.0,4/16,14.25%,ACOT6;NUDT7;ACOT9;ACOT1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.38529677472405927,-1.1899771846307798,0.19487179487179487,0.5722550382529196,1.0,11/22,29.41%,DUSP10;PPM1F;DUSP7;MTMR3;DUSP6;DUSP19;DUSP15;MTMR2;DUSP4;CDKN3;DUSP18
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4399412072930989,1.1878627211955037,0.1932418162618796,1.0,1.0,14/73,18.00%,AVPR1A;VIPR2;F2R;GLP2R;S1PR2;CRHR1;LTB4R2;INPP5K;GPR37L1;TSHR;GPR37;LHCGR;SORCS1;RXFP1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.47438856068776064,1.1848604763105504,0.2537313432835821,1.0,1.0,11/38,15.33%,NCF4;SESTD1;PLEKHF1;ATG2B;WIPI2;PLEKHA4;WDR45B;SNX21;ATG2A;DENND1A;PLA2G4E
prerank,DNA polymerase activity (GO:0034061),0.5029762257931285,1.1846628754393784,0.2595797280593325,1.0,1.0,9/22,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,cytokine receptor activity (GO:0004896),0.4301230898286807,1.1826630609885187,0.22152560083594566,1.0,1.0,11/83,15.34%,IL4R;GHR;IL1RL1;CD44;IL17RA;IL10RA;ACKR4;CSF2RA;FLT3;CNTFR;FZD4
prerank,insulin-like growth factor I binding (GO:0031994),0.5544370021668615,1.180931522357882,0.26266666666666666,1.0,1.0,4/13,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5266476430484617,1.180650529541124,0.2739018087855297,1.0,1.0,2/16,4.54%,SLC1A5;SLC1A6
prerank,peptidase inhibitor activity (GO:0030414),0.47378940963979055,1.1804275720655895,0.23798358733880423,1.0,1.0,7/33,12.41%,TIMP2;GPC3;UCHL5;CAST;CSTB;SLPI;RECK
prerank,anion:anion antiporter activity (GO:0015301),0.5358932028348699,1.180058179878425,0.28326745718050067,1.0,1.0,5/17,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC25A4;SLC26A6
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5546522540127993,1.1759723462863747,0.2865013774104683,1.0,1.0,5/13,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,myosin binding (GO:0017022),0.44124132453525833,1.1750216360065462,0.23758099352051837,1.0,1.0,17/55,20.96%,MYOC;GSN;RAB6A;LLGL1;RAB6B;TRAK2;RAB3D;MOBP;RHOA;TRIOBP;RAB27B;GIPC1;CXCR4;ARFGEF1;RALA;RAB10;PYCARD
prerank,poly-purine tract binding (GO:0070717),-0.35456384797154605,-1.1741385500942088,0.22413793103448276,0.5986922851617241,1.0,11/27,19.35%,RBPMS;ATXN1;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3;PNPT1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.46309904245089034,-1.173206650497903,0.24444444444444444,0.5900957468368321,1.0,3/11,4.38%,SGMS1;PIGN;SAMD8
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4825964058408877,1.1731714389282113,0.2715466351829988,1.0,1.0,12/31,22.48%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,snoRNA binding (GO:0030515),0.47530431576216553,1.172585859834239,0.26976744186046514,1.0,1.0,16/30,29.12%,NUDT1;NUDT7;NUDT16L1;GAR1;DDX21;NUDT16;XRCC5;SNU13;NUDT5;NUFIP1;TBL3;PRKDC;NOP56;TSR1;NHP2;NOP58
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5466032073132426,1.172152111187171,0.2927864214992928,1.0,1.0,4/12,6.99%,GNAS;IRS1;SOCS2;YWHAG
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.45136935828170544,-1.171517140420502,0.2868217054263566,0.5834612663741862,1.0,5/12,19.65%,H3-3A;POU2F1;STAT1;GTF2B;TAF1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.45202538508108,-1.170115340309978,0.2851985559566787,0.5761298482005606,1.0,2/11,8.69%,SLC22A4;SLC25A20
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5515009907301794,1.168510751677638,0.3008241758241758,1.0,1.0,5/12,18.36%,TENT5B;TENT4A;PAPOLB;TENT2;TENT4B
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.5421394764686097,1.1681580670512013,0.28974358974358977,1.0,1.0,5/15,17.09%,SLC26A5;SLC4A8;SLC4A3;SLC26A6;SLC26A1
prerank,alkali metal ion binding (GO:0031420),-0.4450560775433954,-1.1666616815558901,0.28286852589641437,0.574055108939444,1.0,2/13,3.29%,ATP1A2;PDXK
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.44576650006725804,-1.1654403787319794,0.25,0.567138673417232,1.0,2/11,3.60%,SASH1;DAB2IP
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.49349737380424874,1.164356098161885,0.2884371029224905,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.49349737380424874,1.164356098161885,0.2884371029224905,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5422615495386393,1.1636929802666895,0.3097463284379172,1.0,1.0,3/14,5.83%,RPP25;RPP21;PRORP
prerank,mechanosensitive ion channel activity (GO:0008381),0.5619899853596549,1.1617395632266998,0.2855209742895805,1.0,1.0,2/12,5.18%,PIEZO2;TMEM63A
prerank,leucine zipper domain binding (GO:0043522),-0.456416195855276,-1.1594864195825296,0.25666666666666665,0.5705688646480214,1.0,1/10,0.28%,PAWR
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4735058633088857,1.1594106423636998,0.2822966507177033,1.0,1.0,10/28,23.63%,RPP25;RPP21;PRORP;AGO2;NUDT16L1;NUDT16;POP4;AGO3;RPP30;EDC3
prerank,peptidase activator activity (GO:0016504),0.49773270659467617,1.1589732400007526,0.2816377171215881,1.0,1.0,4/22,8.52%,PCOLCE2;PCOLCE;ADRM1;CLPX
prerank,protein heterodimerization activity (GO:0046982),-0.24001456792562165,-1.158406356456364,0.0,0.5631228212705063,1.0,29/178,9.11%,TCF4;ATP1A2;BMP6;TPM1;TENM4;BCL2L1;MEF2C;EPAS1;BCL2;ARNT2;YWHAH;ADRA1B;RALGAPA1;ZHX3;ITGA3;KCNB1;KCNB2;AHR;ABCG1;IRAK2;AGTR1;PSMF1;MICU2;IKBKG;MIGA2;ZHX1;ADRA2A;ERBB2;SMC3
prerank,chemorepellent activity (GO:0045499),0.486996144564916,1.1564911674499554,0.27548543689320387,1.0,1.0,5/25,12.28%,SEMA3C;DPP4;SEMA3A;NRG3;SEMA3D
prerank,RNA polymerase binding (GO:0070063),0.5101963759681314,1.1560305813609264,0.2979539641943734,1.0,1.0,5/18,12.63%,BIN1;SCAF8;TCERG1;ANP32B;ZFP36
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5567455221504172,1.1558145129822517,0.31700680272108844,1.0,1.0,2/12,6.28%,IRS1;SH2B1
prerank,death domain binding (GO:0070513),-0.4438721129424673,-1.1554942292852777,0.29389312977099236,0.5605050315259517,1.0,4/11,11.69%,BCL2L1;BCL2;DAPL1;RIPK1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5111459387324964,1.1548748159988804,0.3,1.0,1.0,4/18,6.87%,AKR1B1;ALDH18A1;ALDH3A2;FAR1
prerank,regulatory RNA binding (GO:0061980),0.4516240057039964,1.154540240336336,0.296962879640045,1.0,1.0,11/38,19.45%,TARBP2;HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4625683556319768,1.153672643876105,0.2842465753424658,1.0,1.0,12/33,21.44%,MAF1;SCAF8;RTRAF;NCOA3;SPTY2D1;AGO2;ELP4;URI1;UVSSA;ERCC5;RRN3;PAF1
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4712802495335663,1.1528992235274969,0.27686915887850466,1.0,1.0,13/34,22.48%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UFC1;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,R-SMAD binding (GO:0070412),0.5141415487085113,1.1528848441547392,0.3139240506329114,1.0,1.0,8/18,22.02%,LDLRAD4;PMEPA1;SMAD4;SMAD6;DDX5;PPM1A;JUN;SMURF1
prerank,protein tyrosine kinase binding (GO:1990782),0.4301885483370697,1.1522213877166732,0.2598509052183174,1.0,1.0,10/71,10.44%,NOX4;ANGPT4;PIK3R2;ACVR1;BANK1;GAS6;FLT3LG;NRG3;SIRPA;SQSTM1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4963916688631196,1.1516993870827563,0.3060179257362356,1.0,1.0,10/21,21.50%,ACBD3;WASF1;GSKIP;AKAP14;AKAP8;AKAP9;AKAP1;ARFGEF1;PRRC1;AKAP8L
prerank,ribonuclease activity (GO:0004540),0.4336786605031584,1.1514223378039765,0.26868905742145177,1.0,1.0,13/56,15.16%,DIS3L2;ANG;RNASE4;NYNRIN;AGO2;EXOSC7;SAMHD1;ERN1;RNASE6;RCL1;ZC3H12A;EXOSC1;SMG6
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5737259361455591,1.151334724396348,0.31888111888111886,1.0,1.0,4/10,12.08%,DSC2;CD47;SIRPA;JUP
prerank,insulin-like growth factor binding (GO:0005520),0.5281113474040989,1.145535257511593,0.2982689747003995,1.0,1.0,4/15,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,nucleotidyltransferase activity (GO:0016779),0.49393253665362047,1.144415389783681,0.31505102040816324,1.0,1.0,9/19,23.90%,PAPSS2;TENT4A;CGAS;YRDC;NUDT5;TENT2;TENT4B;CRPPA;REV1
prerank,epidermal growth factor receptor binding (GO:0005154),0.4778135946086568,1.1429671895330655,0.29878048780487804,1.0,1.0,8/25,16.67%,AREG;BTC;ARF4;SNX1;ATXN2;EGF;FER;EFEMP1
prerank,sodium channel regulator activity (GO:0017080),0.4489553027993815,1.142177687729363,0.3028169014084507,1.0,1.0,11/37,20.22%,FGF13;SGK3;SGK2;ATP2B4;CAMK2D;FXYD5;SCN4B;PRSS8;FGF14;GPLD1;PTPN3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4465451832537541,1.1411645124001977,0.29068462401795736,1.0,1.0,14/42,24.09%,SYK;IRS1;PIK3R2;ABL2;YWHAE;PIN1;PTPN5;RASA1;PTPN3;YES1;YWHAB;VAV2;SH3BP2;NCK2
prerank,telomeric DNA binding (GO:0042162),0.4565104137204732,1.1400479843168227,0.29940828402366865,1.0,1.0,15/32,28.52%,CTC1;ACD;HNRNPD;XRCC5;TERF1;SMG7;SMG6;RAD50;BLM;TINF2;TERF2IP;UPF1;SMG5;STN1;XRCC6
prerank,manganese ion binding (GO:0030145),0.44137443516355523,1.1394131959022988,0.2947019867549669,1.0,1.0,18/48,26.91%,B4GALT1;MGAT1;ABL2;XPNPEP3;DYRK2;LARGE1;GALNT1;NUDT16;MPPE1;MGAT5;MGAT2;NEK4;XYLT2;MGAT5B;ADCY2;GALNT4;XXYLT1;ADPRM
prerank,triglyceride lipase activity (GO:0004806),0.495338522161192,1.138417698319111,0.32605905006418484,1.0,1.0,5/20,18.64%,CEL;LCAT;DAGLB;LIPC;LIPH
prerank,phosphatidate phosphatase activity (GO:0008195),0.5303431386218769,1.1382119599441423,0.3342245989304813,1.0,1.0,6/13,20.27%,PLPP3;PLPP5;PLPP1;PLPPR3;PLPP2;LPIN3
prerank,ribonuclease P RNA binding (GO:0033204),0.5609925977518286,1.1367580944078997,0.3128491620111732,1.0,1.0,5/10,26.60%,RPP25;RPP21;POP4;RPP30;RPP14
prerank,BMP binding (GO:0036122),-0.446858621347496,-1.1360970551808223,0.30689655172413793,0.5948622343676815,1.0,3/11,7.95%,ENG;GREM2;BMPR2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.49746014628483914,1.134887468746798,0.29662077596996245,1.0,1.0,8/20,18.84%,MAGI3;DLG2;AK2;MPP1;CMPK2;AK8;AK9;CARD11
prerank,GDP binding (GO:0019003),0.4225142755047786,1.1332569841455726,0.2840300107181136,1.0,1.0,26/63,27.93%,GNAI3;RAP1B;RIT2;DYNC1LI1;RAB2A;NRAS;KRAS;RRAGD;NME2;ARF6;GEM;RAB27B;RAB35;RAB5B;RAB5C;RRAS2;RALA;RAB10;RAB18;RAB12;RAB29;RAP1A;DIRAS2;RHEBL1;RAB8B;RAP2B
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5682751904891477,1.1332308022347806,0.3246217331499312,1.0,1.0,4/10,24.78%,KAT2B;CDKN1A;CDKN2C;HEXIM1
prerank,hormone receptor binding (GO:0051427),0.5234040594194393,1.1331543296843183,0.34358288770053474,1.0,1.0,5/14,28.27%,SOCS2;ADCYAP1;NCOA6;NPPC;JAK2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.4629043168952949,-1.1325832893606727,0.32525951557093424,0.5929926913909519,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,flavin adenine dinucleotide binding (GO:0050660),0.42899848803654606,1.132452890248888,0.30386740331491713,1.0,1.0,11/53,15.89%,NOX4;ETFA;AIFM2;ACADVL;MICAL2;NQO2;POR;PPOX;AOX1;ACOX1;ETFDH
prerank,metal ion binding (GO:0046872),0.38814890841596955,1.130122339796627,0.103,1.0,1.0,93/477,19.24%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;GCLC;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;MAPK12;DIS3L2;SYT2;POSTN;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;IRAK3;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A8;S100A9;SMOC2;SLIT1;SYT12;SYT11;CALU;FOXK2;DSC3;DSC2;COLEC11;SYT13;MVK;RCN3;THBS4;RET;IDH1;EYA2;ABL2;UBA2;PKD2;S100A6;CAPN1;IQGAP1;NDUFAB1;CDH22;ERN1;DYRK2;CAMKK2;CALML4;MAP3K6;NUDT16;CERK;FAN1;GLCE;CALM2;ATP2A2;S100G;CASQ1;STK3;PPP3CA;TUBB4A;GEM;DNASE1L2;CHP1;PLA2G4E;NUDT5;ANXA4;NME1;CANT1;PADI2;SYT1;ANXA8;ANXA8L1;TPM4;ADPRH;NCS1;STK38;EFCAB9;RP2;EML1;IDH3G;PPP3CB;STIM1;TNNC2
prerank,AMP binding (GO:0016208),-0.4332363551147979,-1.1296165111192207,0.3159722222222222,0.5898974818997857,1.0,5/11,13.12%,PRKAG2;PFKM;PRKAG3;ACSS2;PFKL
prerank,transcription coregulator binding (GO:0001221),0.43270684937904663,1.128155033145529,0.30528586839266453,1.0,1.0,20/50,25.29%,AR;ESR1;SMAD4;NR1D1;HDAC6;PHF1;CDK9;HDAC3;EHMT2;PER1;CTCF;CIT;RPL23;CTBP1;EZH2;RORA;PER3;RELA;LCOR;CHD6
prerank,vinculin binding (GO:0017166),0.5357528556780039,1.1280374269452866,0.34702549575070823,1.0,1.0,2/11,3.91%,CORO2B;SORBS3
prerank,ion gated channel activity (GO:0022839),0.4843309507841303,1.126786408858591,0.3462940461725395,1.0,1.0,3/24,5.18%,KCNT2;ANO3;TMEM63A
prerank,FAD binding (GO:0071949),-0.3439272170322344,-1.1254687126748981,0.2828282828282828,0.5899187764947496,1.0,5/24,7.86%,MICAL3;DDO;PRODH;CRY1;AGPS
prerank,lipid phosphatase activity (GO:0042577),0.5190211263956439,1.1223114563775882,0.3426666666666667,1.0,1.0,6/14,17.79%,PLPP3;PLPP1;PLPP7;INPP5K;PLPPR3;PLPP2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.422752295786518,1.1221318545774572,0.3185745140388769,1.0,1.0,16/60,14.52%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;TGFBR2;ACVR1;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1
prerank,MHC class II protein complex binding (GO:0023026),0.5438170549773955,1.1191533739555464,0.34642356241234223,1.0,1.0,4/11,15.67%,CD81;YWHAE;HSP90AA1;PKM
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5442911274533286,1.1182823422533374,0.328748280605227,1.0,1.0,5/11,16.05%,NUDT1;NUDT7;NUDT16L1;NUDT16;NUDT5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.46955090803086963,1.1181310053350892,0.3268529769137303,1.0,1.0,8/26,22.43%,B3GALNT1;CSGALNACT2;B4GALNT4;CHSY3;B3GNT8;B3GALNT2;CHPF;CHPF2
prerank,transferrin receptor binding (GO:1990459),0.5456972249375404,1.1176006038189992,0.33821376281112736,1.0,1.0,3/10,8.18%,SNX1;CD81;CHUK
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.44885373461214617,1.1162444453364244,0.33890214797136037,1.0,1.0,2/28,3.23%,TNFSF9;TMBIM1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5341899536198522,1.1151723387206072,0.3546099290780142,1.0,1.0,5/11,31.65%,PRMT2;FBXO11;CARM1;PRMT8;PRMT7
prerank,potassium ion leak channel activity (GO:0022841),0.5068635526339137,1.1129949425166525,0.3552278820375335,1.0,1.0,3/15,9.44%,KCNK5;KCNK13;KCNK9
prerank,carboxy-lyase activity (GO:0016831),0.4742308718661088,1.1126654489165728,0.35018050541516244,1.0,1.0,9/23,25.37%,UMPS;GGCX;ODC1;BCKDHA;UXS1;AZIN2;AMD1;UROD;MVD
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4408368518391006,1.1126261566929059,0.3275862068965517,1.0,1.0,14/34,28.58%,CKS1B;ETAA1;STRADA;IQGAP1;CALM2;DBF4;STK3;MAP2K2;CAB39;ALS2;PARP16;CKS2;FAM20A;INCENP
prerank,double-stranded DNA binding (GO:0003690),0.3801196888755843,1.1109164689410465,0.146,1.0,1.0,80/531,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;NFIX;IRF4;EGFR;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;KLF2;RAD51B;JUND;ZBTB12;NFATC4;MAFF;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;MND1;TARDBP;DPF1;CGAS;SMAD5;MTF1;HOXA4;GLI2;TBX6;ETV3;SOX8;NR6A1;MYBL2;FOXC2;ONECUT1;POLG2;MBNL2;CPSF4;ATF7;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;DDX11;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,CXCR chemokine receptor binding (GO:0045236),0.5437522009252654,1.11075356818794,0.37551020408163266,1.0,1.0,2/11,6.20%,ITCH;CXCL10
prerank,WW domain binding (GO:0050699),0.4529454304327171,1.1093815995522085,0.35523114355231145,1.0,1.0,8/26,21.95%,SCNN1B;PMEPA1;TCEAL6;KIF20B;NDFIP1;WBP1;TCEAL9;TRAF4
prerank,histone deacetylase activity (GO:0004407),0.4831977258142846,1.1069735680182051,0.35887611749680715,1.0,1.0,7/19,20.07%,HDAC9;HDAC6;SIRT2;HDAC3;HDAC4;SUDS3;MIER1
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.43996418862862047,1.1061406573000607,0.32547169811320753,1.0,1.0,7/38,12.89%,SERPINB8;ANXA2;SERPINE3;SERPINF1;SERPINH1;SLPI;SERPING1
prerank,chemokine activity (GO:0008009),0.446872509689901,1.1056615091971964,0.347010550996483,1.0,1.0,4/31,12.90%,CCL8;CXCL10;CCL25;CCL13
prerank,palmitoyltransferase activity (GO:0016409),0.45108795899550574,1.1056608133616348,0.3392857142857143,1.0,1.0,11/28,23.21%,ZDHHC16;ZDHHC7;HHAT;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,RNA binding (GO:0003723),0.37614223809641745,1.1050251843332357,0.051,1.0,1.0,496/1321,29.16%,COL14A1;DCN;RPSA;AHNAK;DDX18;SRSF2;LRP1;C1D;AFF2;ZC3H8;MBNL1;DNM1;PKP3;RPP25;EIF3B;FNDC3B;TARBP2;ADARB1;MTHFSD;HNRNPA1;MRPS11;ANG;ANXA2;ALDH18A1;SRSF6;DIMT1;NXF1;HDLBP;NYNRIN;RFTN1;RRBP1;DDX19B;ABT1;RBMS3;USP36;URB1;DDX49;DHX16;ZFP36L1;TNS1;DAZL;TRMT6;NUDT1;RBM4;CLUH;GTPBP4;KRI1;EIF4A1;RPP21;GNL3L;ZCRB1;ERI3;SUGP2;DDX42;SCAF8;USP10;SAMD4B;NUDT7;KCTD12;KPNA2;DDX51;CFAP65;RBBP6;RTRAF;RCAN3;TRMT2A;UBAP2L;TARDBP;DGCR8;IGHMBP2;C1QBP;MEPCE;SYNE1;FSCN1;YWHAG;DNAJC2;RC3H1;UCHL5;SRP19;LSM4;FNDC3A;CLTC;TDRD3;MYO5A;FCF1;NOC2L;DHX33;U2AF1;SPATS2;POLR1G;CAST;SRSF3;UBE2N;ZFP36L2;ATXN2;NSRP1;USO1;YWHAE;DYNC1LI1;LARP4;CHCHD1;PRPF3;GPATCH1;MRPL13;NUP98;CPSF6;AGO2;DUSP11;DALRD3;ESF1;HNRNPD;RBM22;NOP9;TDRD7;NUDT16L1;GAR1;KHDC4;EXOSC7;SAMHD1;LGALS1;SIDT2;EIF1;SRP9;ARF1;SELENOH;MEX3A;MRPS27;HELZ2;MBNL2;SON;CSTB;CPSF4;CHD2;SMC1A;GSPT2;HNRNPH1;YRDC;RRP36;NPM1;MAPRE1;RPL10A;WDR46;TCERG1;ZC3HAV1;SERPINH1;DDX56;DDX21;DHX8;ASCC3;SEC23IP;MRPL10;HNRNPUL2;GFM1;CELF2;DAP3;PEG10;UBTF;MAPT;SARS2;RBFOX2;GTPBP10;NUDT16;SLPI;PUM1;PRPF40A;IGF2BP1;UNK;PSTK;SRSF11;EIF3A;FLNB;XRCC5;LARP1;SBDS;ZFP36;RPP25L;POLR2D;RPS27L;POLR2G;MPHOSPH10;DDX17;RPS5;RPGR;ZCCHC24;SNU13;DNA2;AKAP8;EIF2S1;ATXN2L;NOLC1;ELP1;DDX11;HNRNPA3;DCAF13;DDX4;LLPH;TRMT10B;AQR;POLDIP3;ZC3H12A;RBM3;RRP7A;NUFIP2;EXOSC1;PNISR;MRM3;SMG7;CISD2;THOC2;PTCD2;HSP90AA1;MRPL3;SEC63;DDX50;EIF3E;SF3B4;GSPT1;ZC3H11A;DIAPH1;TRMT1;GTF2F1;BTF3;SMG6;FYTTD1;MRPL21;DYNC1H1;DDX20;ZCCHC8;MDH2;MANF;RSL1D1;RPL6;NOP53;BAG4;DDX52;MAP4;PKM;PRPF38B;PPIL4;HMGB3;SNTB2;PDIA3;CCDC124;GRWD1;POP4;SF3A1;NUDT5;PSIP1;SPTBN1;RBM33;CPSF2;RTCA;PHF5A;EIF3D;PPP1CC;DDX5;SNRPA;CHD3;SNRPG;FXR2;SNRPD3;SAP18;AGO4;NME1;PNN;ABCF1;PPIA;NUFIP1;ILF2;RCC2;PWP2;YTHDF1;SNIP1;YTHDF2;LUC7L3;DDX31;RCC1L;DDX39A;IPO5;SRRM1;EPRS1;FKBP4;RPF2;RBM6;NAA15;ARCN1;AKAP1;EIF2S2;EBNA1BP2;RBM39;PUF60;ZBED4;TENT4B;METAP2;NCBP3;SUPV3L1;SLBP;SRFBP1;STRAP;TCF20;ALDOA;TYW5;AIMP1;NOC3L;DDX24;ARL6IP4;HNRNPUL1;SRRM3;UBFD1;U2AF2;DUS2;PTCD1;MEX3C;MCAT;AGO3;TBL3;LUC7L2;RPL22L1;RPL23;RPL17;NOL10;KMT2C;ELAVL2;PDCD11;NOVA1;LSM7;XPOT;PTBP1;GTF2E2;FLNA;ANXA7;KRR1;REPIN1;RBM28;GANAB;SF3B2;SF3B1;RPS25;ZCCHC17;RBM45;MTIF2;SRPK1;TEP1;MAK16;PRR3;NEMF;AKAP8L;THRAP3;RC3H2;KIN;IMMT;EIF2A;JUN;RPP30;LARP7;PTBP2;PRPF38A;GPKOW;DUSP14;PLEC;NOP2;RSL24D1;YTHDF3;RBM5;RNMT;TPR;NOC4L;BAZ2A;SNRPA1;ZC3H4;PURG;MRPL54;EDC3;CSTF2T;RRP1B;TRAP1;CCT4;TNRC6A;EIF4G3;DAZAP1;EIF3L;RTF1;BRIX1;DIDO1;EIF4H;RALY;AGFG1;CPSF7;SCAF4;NOA1;MKRN2;G3BP1;WDR33;RTN4;PSMD4;API5;PABPN1;SEC61B;KHNYN;MARK2;PPIG;HEXIM1;CALR;MTCL1;LARP6;RPL22;CELF3;EWSR1;PARP12;RAMAC;EXOSC10;S100A16;PHF6;HSP90B1;TNPO1;APEH;ERAL1;UBAP2;DHX32;FBRSL1;ALYREF;UPF3B;CEBPZ;H1-0;OTUD4;CSNK1E;ZNF638;R3HDM1;DCP1A;LRRC59;MRPL14;DCP1B;RBMX;EIF4G1;NOP16;CRNKL1;FTSJ3;PRPF6;TASOR;KPNB1;RPP14;SAFB;EIF4E2;DHX29;GDI2;CCDC9;BZW1;CMSS1;RSRC2;UPF1;DDX1;MRPL12;LSM5;SMG5;PRKDC;CDC40;RPL34;HTATSF1;THOC5;ZFR;AGO1;NOP56;AATF;TSR1;DUT;CCT6A;NHP2;CELF1;YARS1;TBL2;CPSF3;ZRANB2;SARS1;RPS26;GOT2;CCDC86;LSM1;MRPS23;RBM15;MYH10;MSI1;XRCC6;HNRNPC;SNRPC;CNBP;WBP11;ATP5F1A;SRSF5;WDR43;PDIA4;PEBP1;UTP18;IGF2BP3;DHFR;NOP58;SUMO1
prerank,ligand-gated cation channel activity (GO:0099094),0.4042392326515658,1.1046135099029435,0.31236673773987206,1.0,1.0,18/75,24.46%,SCNN1B;P2RX3;GRIN3A;KCNJ2;GRIN2D;GRIA2;KCNJ3;ASIC2;GRIN2A;CHRNA7;CHRNA5;KCNH2;GRIA3;ASIC1;GRIK5;GRIK2;KCNJ11;GRIK4
prerank,sequence-specific DNA binding (GO:0043565),0.3772980609848774,1.1019862960728943,0.134,1.0,1.0,90/590,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;CTC1;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;CXXC1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;FOXL1;ACD;ETV3;SOX8;WDR77;NR6A1;MYBL2;FOXC2;HNRNPD;ONECUT1;MBNL2;CPSF4;ATF7;CSRNP3;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;HDAC4;RFX5;SMG7;PLAGL2;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,endopeptidase inhibitor activity (GO:0004866),0.40073316128372527,1.1004686949154046,0.33719704952581664,1.0,1.0,14/82,12.89%,TIMP2;SERPINB8;ANXA2;BIN1;SERPINE3;CARD16;UCHL5;CAST;SERPINF1;CSTB;SERPINH1;SLPI;RECK;SERPING1
prerank,protein kinase inhibitor activity (GO:0004860),0.42704551593486106,1.0976061035412696,0.3511705685618729,1.0,1.0,16/42,25.02%,CAMK2N1;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;IBTK;DUS2;CIT;YWHAB;HEXIM1;DNAJC3
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.43710945791619504,1.097195736734469,0.35517241379310344,1.0,1.0,17/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;EPRS1;QARS1;EARS2;NARS1;YARS1;SARS1;DARS1;WARS2;AARS1;LARS2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5340894597886151,1.0968578245237213,0.37110481586402266,1.0,1.0,3/11,19.05%,CNGB1;HCN4;HCN1
prerank,snRNA binding (GO:0017069),0.43009430330008785,1.0965671817521914,0.37024608501118567,1.0,1.0,15/42,24.78%,MEPCE;LSM4;PRPF4;CDK9;RBM22;SNRPB2;DDX21;SNU13;SNRPA;SNRPD3;LSM7;LARP7;SNRPA1;COIL;HEXIM1
prerank,phosphotyrosine residue binding (GO:0001784),0.4368322832043806,1.095883765145197,0.35926773455377575,1.0,1.0,4/37,7.45%,SYK;IRS1;PIK3R2;ABL2
prerank,transcription corepressor binding (GO:0001222),0.4623039487216093,1.0955545108574927,0.3588235294117647,1.0,1.0,12/27,24.39%,ESR1;NR1D1;HDAC6;PHF1;HDAC3;EHMT2;PER1;CTBP1;EZH2;RORA;PER3;LCOR
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.3523880835910496,-1.0950411673027203,0.3069306930693069,0.6494653989456899,1.0,3/21,1.51%,PDE1A;PDE7B;PDE3A
prerank,antiporter activity (GO:0015297),0.4696966731093051,1.09473535615877,0.3642052565707134,1.0,1.0,5/20,16.60%,SLC35E3;ATP1A3;SLC25A16;SLC35D1;SLC35E1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34280564409209596,-1.0931846008147101,0.32653061224489793,0.6440251371952433,1.0,3/23,1.51%,PDE1A;PDE7B;PDE3A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5166318255633707,1.0928729185371908,0.3673469387755102,1.0,1.0,4/12,14.86%,AIFM2;DHRS4;NQO2;CRYZ
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4397284928362671,1.091409020210701,0.3710247349823322,1.0,1.0,11/31,22.78%,KCNK5;SLC12A8;SLC12A4;PKD2;KCNK9;KCNA2;SLC12A5;HCN1;SLC12A6;KCNF1;ABCC8
prerank,double-stranded RNA binding (GO:0003725),0.4046867068454675,1.0913519207561027,0.35867237687366166,1.0,1.0,11/70,9.74%,MBNL1;TARBP2;ADARB1;RFTN1;EIF4A1;DGCR8;RC3H1;CLTC;DHX33;AGO2;SIDT2
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3726898162554391,1.0887942307650855,0.173,1.0,1.0,101/597,16.80%,LMX1A;AR;LHX8;ESR1;PAX9;SP9;NFIX;BNC2;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZW10;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;CREBZF;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;DHX33;ETV3;SOX8;NR6A1;MYBL2;FOXC2;SOX5;ONECUT1;SMAD6;RNF10;BRD7;MCM3;MBNL2;CPSF4;MZF1;ATF7;BCL6;CEBPB;GLI3;XRCC5;BACH2;KDM5B;NCOR1;SIX1;DDX11;HDAC4;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;NR2C2;E2F3;CDK5RAP2;GRWD1;CENPC;UBP1;PER1;SNAI2;CHD3;TFAP4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3221305006421929,-1.0879393593828233,0.3333333333333333,0.6470948997993315,1.0,8/32,10.95%,KDM7A;KDM4A;TET1;PHYH;EGLN3;BBOX1;TMLHE;EGLN1
prerank,chloride channel regulator activity (GO:0017081),0.5058481111178549,1.0878386848476747,0.3915900131406045,1.0,1.0,7/14,28.25%,SGK3;STX1A;CHRNA7;WNK2;STX7;CFTR;STX8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3363621994125038,-1.0875620711988578,0.3057324840764331,0.6387066679641358,1.0,7/27,5.75%,SLC22A8;SLC26A7;ANO1;ANKH;SLC39A8;SLC22A6;SLC5A5
prerank,MAP kinase activity (GO:0004707),0.4979046439365056,1.0870848874545893,0.372972972972973,1.0,1.0,4/14,9.77%,MAPK12;MAPK7;MAPK14;MAPK11
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.4954543170351352,1.0868619190438744,0.3754993342210386,1.0,1.0,5/14,21.67%,DESI2;OTUD7B;USP7;MINDY3;USP13
prerank,DNA polymerase binding (GO:0070182),0.47954238904790486,1.0859441678326076,0.3761118170266836,1.0,1.0,6/18,15.16%,FANCD2;ACD;POLG2;HSP90AA1;SMARCA4;SMG6
prerank,cGMP binding (GO:0030553),0.5196815632657914,1.0819543900982955,0.39325842696629215,1.0,1.0,4/11,11.90%,PDE11A;PDE10A;CNGB1;PDE5A
prerank,transforming growth factor beta binding (GO:0050431),0.4577579483804145,1.0818410929069264,0.3815950920245399,1.0,1.0,6/23,11.85%,TGFB3;TGFBR2;ACVR1;ITGAV;TSKU;VASN
prerank,signal sequence binding (GO:0005048),0.4307417062644995,1.0809604818190868,0.3854289071680376,1.0,1.0,18/35,26.59%,KDELR3;KPNA2;KDELR1;CABP1;KDELR2;TNPO2;TIMM22;SEC61A1;PEX5L;IPO5;PEX5;KPNA1;BRAP;RANBP6;AP2M1;TNPO1;KPNA6;KPNB1
prerank,beta-tubulin binding (GO:0048487),-0.31633628006037906,-1.079942920978415,0.3006993006993007,0.6478635318373751,1.0,12/31,16.85%,EML4;GJB6;IFT74;PDCD5;GABARAPL1;GABARAP;SMC3;HTT;TRPV4;PEX14;TAOK1;VAPB
prerank,"DNA binding, bending (GO:0008301)",-0.3994170721653449,-1.0785319317985043,0.3712121212121212,0.6422111613696965,1.0,3/14,3.59%,LEF1;HMGB1;FOXC1
prerank,miRNA binding (GO:0035198),0.4382347597498956,1.0785069486491616,0.3925233644859813,1.0,1.0,10/30,19.45%,HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.39731751356370865,1.076047857389788,0.36084656084656086,1.0,1.0,16/78,15.82%,CAPN5;UCHL1;CAPN2;GPAA1;USP36;USP10;USP29;CAPN1;USP26;USP33;CAPN11;USP48;USP5;PIGK;USP7;PDIA3
prerank,I-SMAD binding (GO:0070411),0.49748520920016326,1.0737702344444573,0.4064602960969044,1.0,1.0,4/13,10.09%,SMAD4;AXIN1;SMAD5;SMAD6
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.47141353706542277,1.073261285441708,0.3944020356234097,1.0,1.0,4/18,16.12%,PIK3R2;SOCS2;WDR91;SOCS6
prerank,Toll-like receptor binding (GO:0035325),0.5165267548534668,1.072203276553719,0.3936899862825789,1.0,1.0,3/11,8.91%,S100A8;S100A9;TIRAP
prerank,TBP-class protein binding (GO:0017025),0.4628703730968057,1.071682284361523,0.37404580152671757,1.0,1.0,5/21,15.51%,ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,sulfate transmembrane transporter activity (GO:0015116),0.4974224208215432,1.0709403462392162,0.4059539918809202,1.0,1.0,4/14,17.09%,SLC26A5;SLC26A11;SLC26A6;SLC26A1
prerank,RNA polymerase II complex binding (GO:0000993),0.42936929460320855,1.0699971275972462,0.3948896631823461,1.0,1.0,16/32,31.70%,SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;UVSSA;ERCC5;PCIF1;PAF1;ELOF1;AGO1;WDR43;SCAF1;RPRD1A;WAC
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.36512759952981555,1.06932201876435,0.222,1.0,1.0,125/731,16.81%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,cholesterol binding (GO:0015485),0.40227913157646206,1.0681693754138681,0.4044943820224719,1.0,1.0,9/47,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;SCP2;OSBPL6;VDAC2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5282084816923239,1.0674014368143572,0.4115983026874116,1.0,1.0,5/10,21.16%,DNAJB2;FAN1;PML;IDE;FAAP20
prerank,SUMO transferase activity (GO:0019789),0.4861100483508913,1.066102556617377,0.4113842173350582,1.0,1.0,8/16,28.11%,RNF212B;CBX4;PIAS3;HDAC4;NSMCE2;MDM2;MUL1;TOPORS
prerank,damaged DNA binding (GO:0003684),0.41016372150044017,1.0659013737709147,0.38461538461538464,1.0,1.0,14/44,22.85%,MPG;ERCC3;RAD1;ERCC4;DDB1;SMC6;FANCG;NBN;ERCC5;POLD1;DCLRE1A;OGG1;SDE2;ERCC1
prerank,actinin binding (GO:0042805),-0.344951539113483,-1.0638933836853888,0.3417085427135678,0.6670447777308735,1.0,4/21,4.69%,PDLIM5;SYNPO2;PROM1;CACNA1D
prerank,N-acetyltransferase activity (GO:0008080),0.4690835366033931,1.0618964774572872,0.3950310559006211,1.0,1.0,6/19,18.79%,GNPNAT1;ATAT1;KAT2B;NAT8;SAT1;NAA50
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5240368686133737,1.0615780334385982,0.39609483960948394,1.0,1.0,1/10,0.43%,SLCO2A1
prerank,lysophospholipase activity (GO:0004622),0.46511985488955243,1.0610027270347526,0.41213653603034134,1.0,1.0,1/20,0.62%,MGLL
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3621445588052419,1.0597681440003208,0.249,1.0,1.0,123/732,16.81%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3609176648927184,1.0596704742914504,0.34168336673346694,1.0,1.0,84/248,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;KLC1;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;VPS4B;ABCG4;RIT2;CLPX;DYNC1I1;TOR1A;KIF2A;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;KIF20B;NKIRAS1;RAB43;PIN1;RHOA;DNA2;RRAGD;GNB1;DDX4;HSP90AA1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;CHD3;RAB35;RAB1B;RAB5B;RAB5C;DYNC2H1;ATP2B1;ATAD1;RRAS2;RAB24;RALA;ABCB10;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;CFTR;DHX29;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,sialyltransferase activity (GO:0008373),-0.34023115794401215,-1.0564582771874191,0.3604060913705584,0.6746183917183466,1.0,6/20,9.82%,ST3GAL6;ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST6GAL1;ST8SIA2
prerank,GTPase activity (GO:0003924),0.36314311243649217,1.0562113152789088,0.3716012084592145,1.0,1.0,65/192,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;RIT2;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;NKIRAS1;RAB43;RHOA;RRAGD;GNB1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;RAB35;RAB1B;RAB5B;RAB5C;RRAS2;RAB24;RALA;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41867328710811114,-1.0553500658133277,0.38434163701067614,0.6684297777558683,1.0,5/10,25.76%,CACNB2;CACNA1D;CACNB3;CACNA1B;CACNB4
prerank,calcium activated cation channel activity (GO:0005227),0.47487097193409866,1.0538799502109721,0.4243208279430789,1.0,1.0,2/17,5.18%,KCNMA1;TMEM63A
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5230571810237851,1.05281710837078,0.42142857142857143,1.0,1.0,5/10,21.16%,DNAJC2;DNAJB2;FAN1;IDE;FAAP20
prerank,mRNA 3'-UTR binding (GO:0003730),0.38925662141303047,1.0524373053619516,0.40191897654584224,1.0,1.0,21/79,16.96%,RBMS3;ZFP36L1;DAZL;RBM4;TARDBP;RC3H1;CARHSP1;AUH;ZFP36L2;LARP4;CELF2;PUM1;IGF2BP1;LARP1;ZFP36;ZC3H12A;CRYZ;RSL1D1;DDX5;FXR2;CPEB1
prerank,deoxyribonuclease activity (GO:0004536),0.4846041999581241,1.0513487151718328,0.417462482946794,1.0,1.0,7/14,24.95%,ERCC4;DNASE1L2;NME1;ERCC5;MAP1S;DFFB;DNASE1L1
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4814387699294224,1.0512677058247508,0.42971887550200805,1.0,1.0,5/15,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3625615428646767,1.0507074085352497,0.3763763763763764,1.0,1.0,48/254,16.80%,PRRX1;AR;ESR1;IRF4;WT1;MEOX2;HSF2;ELF4;GLIS2;RUNX1;SMAD4;ATF5;SOX10;FOXK2;MAFF;NFATC1;HOXA5;CREB3L1;SMARCD2;MEIS2;FOXO1;NFIB;NFIA;MDM4;MTF1;SMARCD1;MYBL2;FOXC2;ONECUT1;SATB2;MZF1;MITF;PRDM15;ZNF112;ATF1;SIX1;RFX5;PLAGL1;PLAGL2;KLF4;HOXA7;HOXC4;MLXIP;NR2C2;E2F3;UBP1;E4F1;TFAP4
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.35875998628486433,1.0503876124932523,0.284,1.0,1.0,133/831,16.81%,LMX1A;EBF2;PRRX1;AR;LHX8;ESR1;HOXA3;PAX9;EBF1;TRPS1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;RBAK;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;ZNF3;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;PEG3;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.4953889879468741,1.0503016793042679,0.4220430107526882,0.998959574852361,1.0,4/12,18.40%,CISD1;CISD2;AOX1;FDX1
prerank,mannose binding (GO:0005537),0.49237131746454355,1.0494695973115502,0.4206798866855524,0.9975494451434109,1.0,3/12,18.60%,COLEC11;LMAN1;MBL2
prerank,transition metal ion binding (GO:0046914),0.3610879360105606,1.0484690541309514,0.344,0.9966164683423709,1.0,100/397,21.58%,TIMP2;LOXL2;SNCB;WT1;SEC24D;B4GALT1;ANG;ANPEP;S100A8;S100A9;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;MGAT1;TK1;RBAK;SEC24A;RASSF1;ABCE1;MDM4;RC3H1;MYT1;MELTF;SLC11A2;LNPEP;ABL2;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;XPNPEP3;USP33;DYRK2;LARGE1;ZNF3;GALNT1;TARS1;WDFY1;RNF7;NUDT16;NQO2;MPPE1;NPEPPS;CZIB;ACO2;KDM5B;MGAT5;MGAT2;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;AOX1;SOD3;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;FBXL5;NEK4;TIMM8B;ZDHHC20;TYR;EPRS1;ARIH2;BLM;MMP16;FDX1;SMPD1;CTCF;TYW5;SCD5;KDM1B;KMT2A;FBXL19;XYLT2;ARIH1;MGAT5B;CCS;TAB2;MBD1;KDM2B;NSD1
prerank,RNA stem-loop binding (GO:0035613),0.5023418873615138,1.044380970789456,0.41895604395604397,1.0,1.0,8/12,34.86%,RC3H1;ZC3H12A;EPRS1;RC3H2;LARP6;MYH10;CPEB3;DDX3X
prerank,phosphatidylglycerol binding (GO:1901611),0.4845607238206114,1.0438963031978834,0.4537037037037037,1.0,1.0,1/13,0.56%,UCP1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4089664541890895,1.0426648708088084,0.4353591160220994,1.0,1.0,8/42,15.13%,CCNL2;CKS1B;KAT2B;CCNC;CDKN1A;CCND1;CCNH;CCNQ
prerank,aminopeptidase activity (GO:0004177),0.43268209715415096,1.0412891531421882,0.42482100238663484,1.0,1.0,11/26,24.69%,ANPEP;LNPEP;XPNPEP3;NPEPPS;LAP3;MMP16;METAP2;METAP1;METAP1D;JMJD7;MMP15
prerank,E-box binding (GO:0070888),0.4152605110710135,1.0405634616397599,0.4090909090909091,1.0,1.0,9/34,16.81%,SCRT2;NEUROD2;BHLHE40;MITF;TWIST1;PER1;SNAI2;TFAP4;ZEB1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.36468797499893846,1.040026528186713,0.4172517552657974,1.0,1.0,32/173,16.81%,TRPS1;FOXP2;SCRT2;SKIL;KLF12;FOXP1;BHLHE40;ZNF25;SKI;FOXK2;ZBTB12;NFATC4;CREB3L1;NR1D1;ZFHX3;ZBTB1;MYPOP;ZNF3;MZF1;MITF;BCL6;CEBPB;PEG3;IKZF5;NACC2;PLAGL1;ZNF692;ZBTB25;ZBTB5;SNAI2;E4F1;ZEB1
prerank,Hsp70 protein binding (GO:0030544),0.4229435818784856,1.0375156061659139,0.45109321058688145,1.0,1.0,12/31,27.95%,DNAJC2;STUB1;DNAJC8;ERN1;PPEF2;DNAJB2;GPR37;DNAJB1;MVD;TSC1;DNAJA1;HDAC8
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.47083101223048934,1.0341799294383192,0.43859649122807015,1.0,1.0,6/16,24.98%,MTMR11;INPP5F;MTMR6;MTMR1;PTEN;MTM1
prerank,semaphorin receptor binding (GO:0030215),0.44122887283912976,1.0313265575786459,0.44209215442092153,1.0,1.0,4/23,12.28%,SEMA3C;RIT2;SEMA3A;SEMA3D
prerank,sulfotransferase activity (GO:0008146),0.42321657213930686,1.0308356574326625,0.4654161781946073,1.0,1.0,6/33,9.57%,CHST1;CHST10;GAL3ST3;CHST12;CHST14;HS2ST1
prerank,nuclear localization sequence binding (GO:0008139),0.4617679458293982,1.0299180162321675,0.43495400788436267,1.0,1.0,10/18,26.59%,KPNA2;CABP1;TNPO2;IPO5;KPNA1;BRAP;RANBP6;TNPO1;KPNA6;KPNB1
prerank,mannosyltransferase activity (GO:0000030),-0.321823358501052,-1.02990983004086,0.37055837563451777,0.71935707401773,1.0,7/21,13.39%,TMTC1;TMTC4;TMTC2;ALG12;DPY19L4;PIGB;POMT2
prerank,poly(A) binding (GO:0008143),-0.33071406348261134,-1.0298392050762206,0.4405940594059406,0.7100884563999784,1.0,9/21,19.25%,RBPMS;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3
prerank,death receptor activity (GO:0005035),-0.40505472967024714,-1.0289820469220317,0.41580756013745707,0.7030842849912391,1.0,5/11,22.93%,TNFRSF19;TNFRSF11A;FAS;TNFRSF10B;TNFRSF25
prerank,glycerophospholipid flippase activity (GO:0140333),0.49941210427665167,1.0278285022473372,0.45518207282913165,1.0,1.0,2/11,7.63%,ATP8B1;ATP11A
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3741392973207606,1.0267548644106845,0.4275132275132275,1.0,1.0,16/75,22.82%,EHHADH;DHRS9;UGDH;DHRS4;HSD3B7;HIBADH;PTGR1;KCNAB3;HSD17B8;MDH2;BDH2;GLYR1;LDHA;HSD17B4;HSD17B11;LDHAL6B
prerank,methyltransferase activity (GO:0008168),0.39306473684800225,1.0222299542559108,0.4541387024608501,1.0,1.0,23/46,34.89%,NTMT1;MEPCE;FTSJ1;COMTD1;COQ3;GAMT;COMT;TRMT11;COQ5;N6AMT1;FTSJ3;EEF1AKMT3;ASMT;NNMT;SUV39H1;PRMT8;LRTOMT;AS3MT;PRMT7;DNMT3B;NSUN3;EEF1AKMT1;BUD23
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.37717898014509865,1.0215658064475417,0.4565677966101695,1.0,1.0,21/69,23.21%,CERS6;ZDHHC16;MOGAT1;PLAAT1;ZDHHC7;SCP2;KAT2B;HHAT;MBOAT7;MOGAT2;ZDHHC2;PLA2G4E;ZDHHC21;ZDHHC20;NAA15;MCAT;SOAT1;ZDHHC18;KAT6B;ZDHHC8;ZDHHC5
prerank,phosphate ion binding (GO:0042301),0.5006572226291575,1.0205792831098737,0.46453407510431155,1.0,1.0,5/10,25.18%,CHST14;ADSS2;MTHFD2;RELA;RPH3A
prerank,sterol binding (GO:0032934),0.3754549895114449,1.020281610791786,0.43028322440087147,1.0,1.0,10/56,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;INSIG2;SCP2;OSBPL6;VDAC2
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2866592782367789,-1.0202015544757113,0.38345864661654133,0.7154573409641072,1.0,7/37,6.74%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;ATP13A3
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2926084785081084,-1.020136538399296,0.3815789473684211,0.7065225095374525,1.0,8/34,9.66%,MYO1B;ADAP2;ARAP2;IQGAP2;ARAP3;FCHSD2;HIP1R;ZFYVE1
prerank,phosphatase binding (GO:0019902),0.3649197930840501,1.0180470716757553,0.4729315628192033,1.0,1.0,26/105,17.67%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;RCAN3;CARHSP1;FBXL2;IQGAP1;SIRPA;ANAPC5;MAGI2;JUP;SHOC2;STX17;KIF3A;PPP1R3C;SFI1;CDC27;GTF2F1;TRPC4AP;ANK1;CNST;TRAF3;SH2D4A;ANAPC4
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3404995215212073,-1.017922907087853,0.42727272727272725,0.7029474078263017,1.0,8/18,20.76%,TNFAIP8;SNCA;XIAP;PRDX3;RPS6KA1;MT3;SERPINB9;BIRC2
prerank,disordered domain specific binding (GO:0097718),0.4328034913963842,1.017540435335375,0.4680589680589681,1.0,1.0,9/23,24.78%,FYN;NCOA3;CLTC;CALM2;HSP90AA1;FKBP8;NUMA1;DFFB;MDM2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4477813910291988,1.0163435174641615,0.4401008827238335,1.0,1.0,4/18,10.09%,TGFB3;TGFB2;TGFBR2;SMAD6
prerank,SH2 domain binding (GO:0042169),0.4074541825659703,1.0161127139260013,0.45871559633027525,1.0,1.0,5/31,12.63%,LAX1;IRS1;SRC;SQSTM1;RUFY1
prerank,MAP kinase phosphatase activity (GO:0033549),-0.38957288148834157,-1.0136335455472822,0.43346007604562736,0.7047707040697937,1.0,3/12,16.45%,DUSP10;DUSP7;DUSP6
prerank,SH3 domain binding (GO:0017124),-0.2573190553652096,-1.0133621513736852,0.4444444444444444,0.696865776632215,1.0,16/62,14.40%,AFAP1L1;CD2AP;AFAP1;SHANK3;DAB2IP;AFAP1L2;PLSCR1;LANCL1;ZNF106;EVL;KHDRBS1;ABL1;CASP9;ABI3;SGIP1;ABI2
prerank,endonuclease activity (GO:0004519),0.38550244249586063,1.0126655543845355,0.464804469273743,1.0,1.0,13/49,20.44%,ANG;NYNRIN;N4BP2;AGO2;ERN1;ERCC4;RCL1;ZC3H12A;SMG6;ERCC5;AGO3;YBEY;OGG1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.467932638277519,1.0113183321502452,0.4768211920529801,1.0,1.0,9/13,35.13%,FTSJ1;TRMT10B;TRMT1;TRMT11;METTL1;WDR4;THUMPD3;TRMT10C;THUMPD2
prerank,solute:proton symporter activity (GO:0015295),0.4643374556523137,1.0111959166081363,0.4788732394366197,1.0,1.0,5/16,15.20%,SLC11A2;SLC17A5;SLC2A10;SLC15A4;SLC25A3
prerank,cholesterol transfer activity (GO:0120020),0.4602582823697776,1.0111126575708247,0.46987951807228917,1.0,1.0,3/16,7.00%,GRAMD1A;OSBPL2;ABCA1
prerank,iron ion binding (GO:0005506),-0.2677544253677589,-1.0095974805878503,0.36082474226804123,0.6976896922702079,1.0,13/48,13.06%,KDM7A;SNCA;FTH1;TET1;PHYH;EGLN3;FECH;PHF2;NFU1;EGLN1;ETHE1;SCD;ISCU
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.46346324776090353,1.0091897365427085,0.4800531914893617,1.0,1.0,5/14,17.91%,NME2;CMPK2;NME1;AK8;AK9
prerank,protein phosphatase 1 binding (GO:0008157),-0.318650924473475,-1.0067107475504655,0.40096618357487923,0.6961942234819392,1.0,6/21,12.82%,PPP1R16B;PPP1R3B;SH3RF2;KCNQ1;PPP1R16A;PHACTR4
prerank,telomerase RNA binding (GO:0070034),0.43281250398551047,1.00570464872127,0.485,1.0,1.0,10/22,28.61%,GAR1;SMG7;SMG6;SNRPD3;TENT4B;TEP1;EXOSC10;SMG5;NHP2;HNRNPC
prerank,zinc ion binding (GO:0008270),0.34640533451346667,1.0049090835141474,0.4874874874874875,1.0,1.0,70/293,21.58%,TIMP2;WT1;SEC24D;ANPEP;S100A8;S100A9;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;TK1;RBAK;SEC24A;RASSF1;MDM4;RC3H1;MYT1;LNPEP;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;USP33;ZNF3;TARS1;WDFY1;NQO2;NPEPPS;CZIB;KDM5B;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;TIMM8B;ZDHHC20;EPRS1;ARIH2;BLM;MMP16;SMPD1;CTCF;KDM1B;KMT2A;FBXL19;ARIH1;TAB2;MBD1;KDM2B;NSD1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.4817434784268979,1.0022005518877009,0.4870395634379263,1.0,1.0,3/12,4.65%,ITGB3;VEGFA;ITGA5
prerank,histone deacetylase binding (GO:0042826),0.3640007446653129,1.001352745209262,0.5025799793601651,1.0,1.0,40/88,30.64%,HDAC9;MEF2D;DACT1;KPNA2;HDAC6;YWHAE;SIRT2;KAT2B;SATB2;HDAC3;GLI3;NCOR2;NCOR1;CCND1;AKAP8;NACC2;HDAC4;HSP90AA1;GMNN;TFAP4;TOP2B;NIPBL;SUDS3;MIER1;KCTD21;AKAP8L;YWHAB;RELA;LCOR;PHF6;SMG5;HES1;HIC1;TP53;MEF2B;BRMS1L;BRMS1;TRAF6;THAP7;RAD9A
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4590392036307111,0.9981855433112357,0.47003994673768307,1.0,1.0,7/15,22.25%,PIK3C2B;PI4K2B;PIK3CA;PI4KB;PI4KA;PIK3CG;PI4K2A
prerank,ribosomal small subunit binding (GO:0043024),0.44582074574032227,0.9974845767652089,0.4974160206718346,1.0,1.0,9/17,26.66%,ABCE1;EIF1;NPM1;LARP1;NME1;MTIF2;EIF4H;ERAL1;DHX29
prerank,CCR chemokine receptor binding (GO:0048020),0.40843867802110756,0.997445179767438,0.5017751479289941,1.0,1.0,5/28,20.70%,CCL8;CCL25;CCL13;MSMP;CNIH4
prerank,MHC protein binding (GO:0042287),0.43091995605948474,0.9970010745697104,0.46776232616940583,1.0,1.0,7/20,28.84%,KIR3DL2;CD81;COL2A1;ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,methyl-CpG binding (GO:0008327),-0.3183462066507804,-0.996816920952901,0.4444444444444444,0.7112079600181225,1.0,5/22,13.13%,CXXC4;TET1;ZBTB38;CXXC5;LRWD1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2850539482285812,-0.9964018150753542,0.4797687861271676,0.7037695975674113,1.0,9/29,18.15%,PRKAG2;PKIG;PRKAR1B;RPTOR;PRKAR2B;SPRED2;HSPB1;INKA2;CIB1
prerank,adenyl nucleotide binding (GO:0030554),0.48041400651668414,0.9951213372783954,0.4942857142857143,1.0,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.48041400651668414,0.9951213372783954,0.4942857142857143,1.0,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,translation elongation factor activity (GO:0003746),0.4537476168402427,0.9944479177493432,0.49269588313413015,1.0,1.0,4/14,20.39%,GTPBP2;GFM1;EEF1B2;EIF5A2
prerank,guanyl ribonucleotide binding (GO:0032561),0.3446903049536748,0.9936359585145642,0.5220883534136547,1.0,1.0,66/196,27.93%,GNAI3;RAB32;RAB6A;GTPBP4;RAP1B;PDE11A;ARF4;SCG5;PDE10A;RIT2;DYNC1LI1;CNGB1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;PDE5A;RRAD;TUBD1;RHOA;RRAGD;NME2;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RAB5B;RAB5C;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;RAB18;ARL8A;NOA1;RAB12;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;RAB8B;TSR1;RAP2B
prerank,glycine binding (GO:0016594),0.4858050719513167,0.993388738220907,0.5154929577464789,1.0,1.0,5/11,30.12%,GRIN3A;GLDC;SRR;GLRA3;GLRA2
prerank,cell adhesion mediator activity (GO:0098631),0.42369300034421514,0.993359336720717,0.5159313725490197,1.0,1.0,7/24,13.54%,NPTN;JAM3;CD47;SIRPA;DSCAM;IGSF9;PALLD
prerank,U6 snRNA binding (GO:0017070),0.4593649767089557,0.9932521766967831,0.48366013071895425,1.0,1.0,5/14,21.92%,LSM4;PRPF4;RBM22;LSM7;LARP7
prerank,phosphatidylinositol binding (GO:0035091),0.3611954161439449,0.9913104512282186,0.5291666666666667,1.0,1.0,17/91,14.55%,SESTD1;SCIN;GAP43;GPAA1;FRMPD2;AIDA;PARD3B;PLEKHF1;SNX1;DPEP1;WDFY1;MAPT;PASK;MPPE1;DENND1A;PIGK;BCAS3
prerank,methylation-dependent protein binding (GO:0140034),0.3764290087489331,0.9911134087353074,0.5194805194805194,1.0,1.0,26/57,30.65%,MORC4;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1;MSH6;ING1;CBX2;ATRX;MBTD1;THAP7;CBX5
prerank,potassium:proton antiporter activity (GO:0015386),0.4949547171883578,0.9904310240685209,0.5291545189504373,1.0,1.0,4/10,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,fibroblast growth factor binding (GO:0017134),0.4262196624630007,0.9902676273824483,0.5141800246609125,1.0,1.0,4/21,9.97%,FGFR1;ITGB3;GLG1;ITGAV
prerank,motor activity (GO:0003774),0.3698849772788277,0.9883363626621482,0.5149892933618844,1.0,1.0,17/60,21.55%,KLC1;KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;PIN1;KIF3B;DYNC2H1;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4274118194463812,0.9880882357659819,0.4968474148802018,1.0,1.0,5/21,27.35%,P2RX3;CHRNA7;CHRNA5;GRIK2;P2RX4
prerank,voltage-gated cation channel activity (GO:0022843),0.35069371614969536,0.9873467765606988,0.527235354573484,1.0,1.0,20/97,19.05%,KCNMA1;KCNV1;CACNA2D2;GRIN3A;KCND1;GRIN2D;PKD2;ITGAV;HCN4;KCNA2;KCNA6;CACNG2;CACHD1;CATSPER3;KCNC2;CACNB1;GRIN2A;NCS1;KCNH2;HCN1
prerank,amyloid-beta binding (GO:0001540),0.3604850375683099,0.9869986070392681,0.5052854122621564,1.0,1.0,19/79,20.22%,EPHB2;APBA3;LRP1;TGFB2;APBA1;ATP1A3;ITGA2;TLR4;GRIA2;TM2D1;HSPG2;FZD4;GRIN2A;CHRNA7;PFDN6;IAPP;GRIA3;ITGAM;BACE1
prerank,acetylation-dependent protein binding (GO:0140033),0.43138241838001423,0.9860483581240392,0.49246231155778897,1.0,1.0,10/20,23.82%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.43138241838001423,0.9860483581240392,0.49246231155778897,1.0,1.0,10/20,23.82%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3789826155610049,0.9847136984811551,0.5137211855104281,1.0,1.0,10/46,13.40%,B3GALNT1;EXT1;MGAT1;POMGNT2;RFNG;LARGE1;B3GNT8;MGAT5;MGAT2;MGAT4B
prerank,protein homodimerization activity (GO:0042803),0.33696731999375934,0.9844782275042842,0.579,0.9984973881823995,1.0,139/589,21.08%,MID1;GHR;LRP6;MGLL;CADM3;FOXP2;SRM;ST3GAL2;DPP4;FGFR1;STK25;FAP;TARBP2;ANG;VEGFA;IRAK3;TGFB2;SLIT2;S100A10;SLC51A;BHLHE40;NECTIN3;SLC39A13;SMAD4;EXT1;MID2;AXIN1;ACVR1;TENM3;VPS4B;CAMK2D;ALDH3A2;PRMT2;ABCG4;DGCR8;IDH1;SYNE1;MLXIPL;TMEM266;STUB1;MYO9B;SNX1;TIMM9;PKD2;S100A6;SLK;CHUK;ZBTB1;INPP5F;NR6A1;HPS4;DPY30;ECE1;PON3;NUDT16L1;ODC1;XPNPEP3;ERN1;NPM1;MZF1;SPPL2B;ZHX2;GSTM2;CEBPB;AKT1;NUDT16;KIF20B;IRAK1;NQO2;GLA;JUP;BAK1;FLRT3;GLCE;ADCY8;ALDH1A3;MGAT2;GDNF;ZDHHC2;GTF2A2;TERF1;CRYM;CR2;NACC2;NFS1;PDGFRA;SYNDIG1;CISD2;HSP90AA1;FZD4;PANK1;MTMR1;AOX1;TRIM68;ACOX1;HARS1;NUDT5;PHETA2;PRPS1;PRPS1L1;FXR2;TFAP4;PML;IDE;CANT1;CHRNA7;PADI2;ABCB9;SRGAP2;QTRT1;ERCC5;TYR;EPRS1;SNX6;TPM4;BLM;SUPV3L1;KCNH2;PRDM9;TYW5;AIMP1;PANK3;MKLN1;MCL1;GLDC;ABCD3;GALM;STK26;ACP3;KMT2A;FLNA;PIP4K2B;NECTIN1;ABCB10;ATIC;HSD17B4;PYCARD;BMPR1A;TPST2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.41719796930571545,0.9843459765220286,0.5111386138613861,0.9953889870122207,1.0,6/23,15.33%,SESTD1;CLVS2;WIPI2;PLEKHA4;WDR45B;PLA2G4E
prerank,phosphatase inhibitor activity (GO:0019212),-0.31744378370382514,-0.9843456673545523,0.4603960396039604,0.7239820205865877,1.0,3/20,4.14%,PTN;LMTK2;BOD1L1
prerank,potassium channel activity (GO:0005267),0.35245662662474897,0.9833161895227909,0.5286757038581856,0.9949666167456698,1.0,11/89,11.20%,KCNK5;KCNT2;KCNMA1;KCNV1;KCND1;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4030212977009477,0.983022344279427,0.5127314814814815,0.9923759518884588,1.0,8/30,19.98%,SLC39A13;SLC39A14;SLC11A2;SLC39A7;SLC25A28;TMEM165;SLC30A5;SLC39A3
prerank,titin binding (GO:0031432),0.46722551060006723,0.982368597676973,0.5041322314049587,0.9907304668045003,1.0,3/13,12.62%,ANKRD23;CAMK2D;CALM2
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33681575123807683,0.9815985201395059,0.557,0.9896243631684016,1.0,119/346,26.47%,SH3RF3;TSPAN17;MIB2;UBE2B;UBE2J2;SMURF2;FBXW8;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RMND5B;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;ANKRD39;UBE2N;UBE2W;FBXO2;FANCL;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;ASB12;HECW2;RNF10;CDC23;TRIM11;IRF2BPL;RNF7;RNF141;UBE2A;CDC34;RSPRY1;LTN1;BSPRY;FBXL3;TRAF3IP2;PEX12;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;RNF138;PML;UBE2G1;FBXL5;FBXO11;ANAPC4;VPS11;ARIH2;UBE2R2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;FBXW2;ARIH1;RNF41;CUL5;KCTD10;RC3H2;UBE2Q2;KLHL9;SMURF1;FBXO24;UBE3A;RNF6;SEL1L;UBE2Z;FBXW11;UBR2;DTX2;RNF114;RNF123;TRIM36;RNF13;TRAF5;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;UBA7;FBXO22;RNF20;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;RNF31;MUL1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3686640651092179,0.9807680156942997,0.5211267605633803,0.9887518591420268,1.0,16/60,16.67%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1;IGF2R;EFEMP1
prerank,leak channel activity (GO:0022840),0.4339484465099664,0.9796214198715003,0.5058670143415906,0.9887493376627811,1.0,3/18,9.44%,KCNK5;KCNK13;KCNK9
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3615687419348443,0.9786417114358915,0.51931330472103,0.9880164162600396,1.0,20/60,21.16%,TIMM50;CDC14B;ILKAP;PPP5C;CTDSP2;PPM1G;PHLPP2;PPEF2;PGAM5;PPP1R3C;CTDP1;PPP3CA;MTMR6;PPP1CC;PDP2;PPP3CB;PPP1R3D;PPM1A;PTEN;PPP6C
prerank,endoribonuclease activity (GO:0004521),0.3955434350498669,0.9786370873205088,0.5237529691211401,0.9846839039658031,1.0,12/32,28.06%,NYNRIN;AGO2;ERN1;RCL1;ZC3H12A;SMG6;AGO3;YBEY;RNASEK;KHNYN;AGO1;CPSF3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44735161956701663,0.9769302854348035,0.5026315789473684,0.9862426238359348,1.0,1/14,0.32%,TIMP2
prerank,methylated histone binding (GO:0035064),0.3692210843828504,0.9767301130013577,0.5382131324004306,0.9835023629176594,1.0,20/62,24.23%,MORC4;DPF2;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.45013002058093204,0.9743519871134151,0.5067385444743935,0.9866214235332208,1.0,5/14,24.98%,MTMR11;MTMR6;MTMR1;PTEN;MTM1
prerank,sterol transfer activity (GO:0120015),0.4388664396130336,0.973813282331517,0.5285524568393094,0.9847910368988385,1.0,3/17,7.00%,GRAMD1A;OSBPL2;ABCA1
prerank,copper ion binding (GO:0005507),0.38147633255367935,0.9722958088392474,0.5348314606741573,0.9856554938346931,1.0,3/42,2.48%,LOXL2;SNCB;ANG
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35970726631883587,-0.9700170673348673,0.4782608695652174,0.7490836755219357,1.0,4/12,8.27%,DCPS;CYFIP2;EIF4E;GEMIN5
prerank,metalloaminopeptidase activity (GO:0070006),0.44010656148379723,0.9695872941328993,0.5160875160875161,0.9900224529180642,1.0,5/16,18.34%,ANPEP;LNPEP;XPNPEP3;NPEPPS;MMP16
prerank,receptor tyrosine kinase binding (GO:0030971),0.36802207860516883,0.9669418836753558,0.5248380129589633,0.9938777481398802,1.0,16/56,23.60%,IRS1;ANGPT4;PIK3R2;SH2B1;GAS6;FLT3LG;NRG3;SQSTM1;CBL;NCK1;DOCK4;PITPNM1;RNF41;GAB2;MAP3K7;CBLB
prerank,G protein-coupled receptor activity (GO:0004930),0.33558092987273236,0.9639860421921217,0.5945945945945946,0.9986406375022037,1.0,21/239,11.84%,ADGRD1;AVPR1A;VIPR2;LPAR3;PROKR2;MTNR1B;GPR12;F2R;LPAR1;GLP2R;S1PR2;ADGRG2;CRHR1;GPR20;LTB4R2;TM2D1;GPR141;GPR161;GPR45;GPR37L1;TSHR
prerank,SUMO binding (GO:0032183),0.44613236266144357,0.963552359031228,0.544137022397892,0.9964184610255231,1.0,7/13,29.74%,CBX4;RNF111;UBA2;PML;SIMC1;HABP4;SERBP1
prerank,protein phosphatase binding (GO:0019903),0.346329245515823,0.9633528826884439,0.5784114052953157,0.9937619281749374,1.0,29/117,19.46%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;GRIN3A;ATP2B4;FOXO1;FBXL2;IQGAP1;SIRPA;MAPT;ANAPC5;SLC9A1;JUP;SHOC2;STX17;ADCY8;KIF3A;PPP1R3C;CDC27;SMG7;GTF2F1;ANK1;TRAF3;PPP1R9B;ANAPC4;PPP3CB;PPP1R3D
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.3964476547959378,-0.9613112552911781,0.4965034965034965,0.7519807355842114,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.3964476547959378,-0.9613112552911781,0.4965034965034965,0.7519807355842114,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3903445174595065,0.9593898556312466,0.5373665480427047,1.0,1.0,6/29,11.99%,MAPK7;MAPK14;PTPRJ;NFATC1;ATF7;TNIP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.35804144546892835,-0.95843971563121,0.4830188679245283,0.7498981413008382,1.0,3/12,7.03%,KDM7A;KDM4A;PHF2
prerank,single-stranded RNA binding (GO:0003727),0.3720608376256043,0.9584171588247852,0.5482796892341842,1.0,1.0,22/43,34.86%,HNRNPA1;AGO2;POLR2D;POLR2G;DDX11;AQR;AGO4;U2AF2;AGO3;PTBP1;EIF4H;EXOSC10;ZFR;AGO1;SNRPC;CNBP;SRA1;FXR1;STRBP;HNRNPU;JMJD6;DDX3X
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3996959256518268,0.9576361629231267,0.5423529411764706,0.9989286585332382,1.0,8/27,15.88%,SLC4A8;SLC9A9;SLC9A1;SLC23A1;SLC8A2;CNNM4;SLC9A7;SLC9A6
prerank,mRNA binding (GO:0003729),0.3345085473861329,0.9576221679732353,0.615,0.9957373222680712,1.0,84/249,26.18%,ADARB1;MRPS11;SRSF6;HDLBP;NYNRIN;RBMS3;ZFP36L1;DAZL;RBM4;CLUH;EIF4A1;SCAF8;SAMD4B;TARDBP;C1QBP;RC3H1;CARHSP1;DHX33;AUH;NSRP1;LARP4;MRPL13;NUP98;CPSF6;AGO2;TDRD7;CELF2;RBFOX2;NUDT16;SLPI;PUM1;IGF2BP1;UNK;EIF3A;LARP1;ZFP36;RPS5;AQR;ZC3H12A;THOC2;CRYZ;ZC3H11A;FYTTD1;RSL1D1;PKM;EIF3D;DDX5;FXR2;CPEB1;YTHDF1;SNIP1;YTHDF2;LUC7L3;EIF2S2;NCBP3;SLBP;SRRM3;LUC7L2;ELAVL2;NOVA1;PTBP1;SF3B1;RC3H2;EIF2A;PTBP2;YTHDF3;RBM5;TPR;EDC3;CSTF2T;EIF4G3;DAZAP1;G3BP1;KHNYN;CALR;LARP6;RBM24;CELF3;RNF20;UPF3B;DCP1A;DCP1B;RBMX;EIF4G1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.36989555916235733,-0.9563546274925964,0.5020080321285141,0.7464570953844151,1.0,4/12,9.63%,PDE7B;PDE3A;PDE8B;PDE2A
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.41567685009013927,0.9552419705615953,0.5477707006369427,0.9989599187491254,1.0,5/21,25.39%,GRM1;CHRNA7;CHRFAM7A;CHRNA5;GRM5
prerank,DNA-binding transcription factor binding (GO:0140297),0.333019591381832,0.9543368163182709,0.5973895582329317,0.9979523315276316,1.0,31/189,15.36%,PRRX1;AR;TLE6;DGKQ;BHLHE40;CRTC2;NFE2L2;HDAC9;HDAC7;MEF2D;SKI;DACT1;TCF7L2;NFATC1;PIAS3;ZFPM2;TBX6;NOC2L;BEX1;TLE2;NPM1;TCERG1;NCOR1;TWIST1;HDAC4;BBS4;DMAP1;NBN;KLF4;TTC8;DDX20
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.39388983413507755,0.9532902042428796,0.5418660287081339,0.99743741767094,1.0,9/29,20.79%,HEXD;PARG;GBA2;GLA;GAA;PGGHG;IDUA;OVGP1;GANAB
prerank,RNA methyltransferase activity (GO:0008173),0.4220216998294051,0.9532156437606601,0.5378690629011553,0.9944458399445374,1.0,4/19,12.67%,TYW3;MEPCE;FTSJ1;TGS1
prerank,ephrin receptor activity (GO:0005003),0.42533030088160395,0.95246089003221,0.5353925353925354,0.989905002309304,1.0,4/17,11.72%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42533030088160395,0.95246089003221,0.5353925353925354,0.989905002309304,1.0,4/17,11.72%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,N-methyltransferase activity (GO:0008170),0.4137789901040717,0.9515657209526871,0.5305105853051059,0.9889981236150387,1.0,7/20,22.63%,DIMT1;FDXACB1;ZCCHC4;TRMT1;TRMT11;N6AMT1;RNMT
prerank,P-type ion transporter activity (GO:0015662),0.4619924048167936,0.9488041661344828,0.5423497267759563,0.9927891981522536,1.0,4/12,18.07%,ATP2B4;ATP6V1E1;ATP2A2;ATP2B1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.4094278428968412,0.9478621493355098,0.5581683168316832,0.9920864969432482,1.0,4/20,14.79%,DESI2;COPS5;USP50;USP7
prerank,endopeptidase regulator activity (GO:0061135),-0.2618024589366259,-0.9478525074818015,0.5681818181818182,0.7571370345752483,1.0,11/40,14.07%,TFPI;ITIH2;SERPIND1;USP14;RENBP;PSMF1;PSME2;PROS1;PSME1;A2M;CST3
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.45215729173833186,0.9464012071661578,0.5409836065573771,0.9928796840235117,1.0,2/12,10.58%,B3GALNT1;B3GNT8
prerank,tau protein binding (GO:0048156),0.3717683186550398,0.9461471471575736,0.5675977653631284,0.9903864395816423,1.0,9/40,14.60%,DCTN1;FYN;BIN1;HDAC6;STUB1;PPP5C;TAOK2;PIN1;HSP90AA1
prerank,actin binding (GO:0003779),0.33156674843968104,0.9461413782968252,0.6251256281407035,0.9873164671513575,1.0,49/170,22.59%,DBN1;GSN;KCNMA1;CORO2B;SCIN;MAP1B;ANG;TNNI3;COBL;ABLIM1;MSRB1;FHDC1;PDLIM7;SYNE1;FSCN1;PFN2;ABL2;MYO9B;FXYD5;NCALD;TWF1;SSH1;AVIL;MICAL2;MAPT;PDLIM1;FLNB;ADCY8;MOBP;GIPC1;CAP1;ARPC1A;EPS8L2;CORO7;CXCR4;COTL1;MICAL1;ALDOA;TNNC2;PDLIM2;GC;MAP1A;FMN2;ABITRAM;SSH3;SPTBN4;MAP1S;CCDC88A;MYO1F
prerank,protein serine/threonine kinase activity (GO:0004674),0.32588102407071007,0.9445378625983377,0.67,0.9882914516490051,1.0,56/335,14.38%,SYK;PRKCA;EGFR;MAPK12;EIF2AK3;RPS6KA2;CAMKK1;CDKL2;DYRK4;MAPK7;IRAK3;SGK3;SGK2;CDK14;TGFBR2;TAOK3;MAPK14;TRIO;ACVR1;CDK4;RIOK1;MTOR;CLK1;CAMK2D;PRKAB2;MAST4;PRKD2;SLK;CHUK;TESK2;CDK9;CDK20;AKT3;BMP2K;NRBP2;MAPK11;ERN1;DYRK2;SQSTM1;CSNK1G1;IRAK4;AMHR2;CSNK1G3;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PRKD3;TAOK2;ULK1;HIPK4;STK24;STK3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.34121639667873493,-0.9442513939370452,0.5152838427947598,0.757268767782254,1.0,5/14,13.76%,MAL;CASP8AP2;BCL2L13;ATP2A3;NOD1
prerank,protein kinase binding (GO:0019901),0.32408885595849357,0.944063962485251,0.698,0.9863723191411925,1.0,95/479,19.06%,NOX4;GHR;AVPR1A;ESR1;LAX1;NELL2;IRS1;DNM1;DCTN1;PRAM1;MAPK7;DACT3;ANK2;CKS1B;IRAK3;CAMK2N1;TNNI3;ADAM9;LLGL1;HDAC9;HDAC7;SKI;PKD1;AXIN1;ACVR1;DACT1;DACT2;MAP2K3;TCF7L2;FAM83G;PTPRJ;PRKAB2;CSK;RBBP6;AP2A2;MAPRE3;TRIP4;BICD1;BANK1;YWHAG;STX1B;CLTC;SLC12A4;PRKD2;PARD6A;SRCIN1;TIRAP;IQGAP1;GSKIP;KAT2B;ITGAV;SIRPA;SQSTM1;NPM1;MAPRE1;IRAK4;ATF7;MAPT;IRAK1;PPEF2;FBXO5;TNIP1;CALM2;ZFP36;SMCR8;TAOK2;CDKN1A;PIN1;CCND1;RHOA;PDE3B;HSP90AA1;TUBA4A;VDAC1;RND3;TRIM68;CDK5RAP2;NSF;RAC3;CAVIN3;KIZ;NBR1;PPP1CC;RNF138;UFL1;RCC2;SNAP91;QARS1;ILK;DOK7;STK38;ATG13;TOP2B;PRKAR2A;IBTK
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.3781103452226005,-0.9437620934429906,0.5451263537906137,0.7502637007649229,1.0,2/10,7.69%,MECOM;PRDM16
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4028047263848509,0.9426689748248076,0.575566750629723,0.9869094360476431,1.0,6/22,16.96%,RBMS3;ZFP36L1;ZFP36L2;ZFP36;ZC3H12A;CPEB1
prerank,neurexin family protein binding (GO:0042043),0.4622229338770066,0.9412104520054094,0.5369318181818182,0.9875220522506485,1.0,2/10,9.16%,CEL;SYTL5
prerank,sodium channel activity (GO:0005272),0.36350937269833256,0.9404954720482029,0.5636574074074074,0.9861789241878002,1.0,12/37,26.21%,SCNN1B;PKD2;HCN4;ASIC2;SCN4B;HCN1;ASIC1;SCN9A;GRIK5;GRIK2;GRIK4;SCN2A
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.26465360533701987,-0.9392706282791288,0.5454545454545454,0.7519540532001604,1.0,6/32,10.39%,KCNB1;KCNB2;KCNS3;KCNQ5;KCNA1;KCNQ1
prerank,rRNA binding (GO:0019843),0.36122103464154554,0.937374829527309,0.5774487471526196,0.9908356933830771,1.0,10/42,19.50%,MRPS11;ANG;MRPS27;DDX21;SBDS;RPS5;NOP53;RCC1L;RPF2;RPL23
prerank,hexosaminidase activity (GO:0015929),-0.35187000318193024,-0.9368963453954564,0.5204460966542751,0.749263350244904,1.0,2/12,3.16%,CEMIP;CEMIP2
prerank,aspartic-type peptidase activity (GO:0070001),0.466253168742469,0.9333501006802236,0.5892351274787535,0.9976323962968519,1.0,4/10,20.22%,PSEN1;NAPSA;CTSD;BACE1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4358618284376128,0.9326002285299224,0.5778961384820239,0.9965791770577823,1.0,2/15,5.90%,SESTD1;PLEKHF1
prerank,histone methyltransferase activity (GO:0042054),0.3790604045834793,0.9306172432381951,0.5817757009345794,0.9982815479916015,1.0,15/32,28.90%,PRMT2;NTMT1;SETD7;SETD2;EHMT2;PRDM9;KMT2C;N6AMT1;CARM1;EZH2;SETDB1;KMT5A;MEN1;SUV39H1;PRMT8
prerank,MAP kinase kinase activity (GO:0004708),0.42587157741666426,0.9305775311974278,0.5757978723404256,0.9953667758476075,1.0,4/15,18.54%,MAPK14;MAP2K3;MAP2K2;MAP2K4
prerank,ATP hydrolysis activity (GO:0140603),0.3581835090786698,0.929312853998792,0.5877689694224235,0.9954573737083701,1.0,12/41,20.66%,VPS4B;ABCG4;CLPX;TOR1A;KIF20B;DNA2;DDX4;HSP90AA1;CHD3;ATP2B1;ATAD1;ABCB10
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.41967063378066966,0.9291639208904457,0.5574412532637075,0.9927815741974048,1.0,2/15,5.45%,PIK3R2;SOCS2
prerank,GTPase inhibitor activity (GO:0005095),-0.3425841417721733,-0.92784510935681,0.5362318840579711,0.7620488884994941,1.0,6/13,10.44%,TNK2;IQGAP2;CPEB2;CDC42SE1;ARL2;RHOH
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.4251225050381302,0.927152098449528,0.577027027027027,0.9945928985288496,1.0,6/15,20.13%,CXXC1;WDR5;PRDM9;KMT2C;SETD1B;KMT2A
prerank,tau-protein kinase activity (GO:0050321),-0.30495381665948273,-0.9269128753668504,0.5487179487179488,0.7564428926584543,1.0,7/20,18.67%,MARK1;DYRK1A;MARK3;TTBK1;CDK5;TAOK1;ROCK1
prerank,kinase binding (GO:0019900),0.3182081151610394,0.9264801576978339,0.749,0.9933088545694885,1.0,102/434,22.28%,GHR;GSN;ESR1;LAX1;EGFR;DNM1;DCTN1;PRAM1;ANK2;DGKQ;CKS1B;PDE8A;IRAK3;TNS2;CAMK2N1;TNNI3;STX1A;LLGL1;DLG4;HDAC7;ATF5;CD160;ATP1A4;SKI;PKD1;AXIN1;MIDN;MAP2K3;TCF7L2;FAM83G;PTPRJ;TTC28;PRKAB2;RBBP6;DLG2;AP2A2;MAPRE3;CARD16;TRIP4;SRC;BICD1;STX1B;STUB1;CLTC;STRADA;SLC12A4;SRCIN1;IQGAP1;GSKIP;KAT2B;SQSTM1;NPM1;MAPRE1;IRAK4;MAPT;IRAK1;FBXO5;PIK3IP1;CALM2;ZFP36;SMCR8;CDKN1A;CCND1;RHOA;TUBA4A;VDAC1;CHP1;RND3;TRIM68;CDK5RAP2;NSF;PER1;RAC3;KIZ;PPP1CC;RNF138;UFL1;TAX1BP1;RCC2;SNAP91;QARS1;ILK;DOK7;ATG13;IBTK;CIT;TOLLIP;IL31RA;OXSR1;FLNA;TIAM1;LYST;MOB1B;CAB39;CDKN2C;NISCH;BTG1;SIKE1;DCTN2;ATF4;DCX;STK11IP
prerank,voltage-gated potassium channel activity (GO:0005249),0.3323246811603023,0.9257383749587947,0.6198952879581152,0.9920705660878516,1.0,11/80,14.62%,KCNT2;KCNMA1;KCNV1;KCNJ2;KCND1;PKD2;HCN4;KCNA2;KCNA6;KCNJ3;KCNC2
prerank,nuclear receptor coactivator activity (GO:0030374),0.34907082375895815,0.9254089356225973,0.596340150699677,0.9899451822412203,1.0,17/52,23.79%,ZMIZ1;FGF2;SFR1;NCOA3;WDR77;ATXN7L3;MED24;HELZ2;SLC30A9;DCAF6;MED13;USP22;THRAP3;CARM1;TMF1;NCOA2;NCOA6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36799973078112747,-0.9248644584736849,0.5321428571428571,0.7533290853915937,1.0,3/10,12.87%,LACC1;ADARB2;APOBEC1
prerank,pyrophosphatase activity (GO:0016462),0.3532984238233979,0.9230632033017636,0.6152125279642058,0.9924079393952009,1.0,20/50,29.07%,ENTPD2;NUDT1;NUDT7;PLPP5;PLPP1;NUDT16L1;NUDT16;ATCAY;NUDT6;NUDT5;PRUNE2;ENTPD6;CILP;LHPP;DHX29;PPA1;ITPA;ADPRM;PPA2;BNIP2
prerank,ubiquitin binding (GO:0043130),0.33903652503982173,0.9219272480502629,0.6167728237791932,0.9920026954745563,1.0,21/73,21.82%,UCHL1;CKS1B;RAD23B;MVB12A;UBE2N;ADRM1;SIRT2;USP33;SQSTM1;DNAJB2;USP5;ILRUN;RBCK1;NBR1;CXCR4;AUP1;UBAP1;TOLLIP;VPS36;USP13;UBXN11
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.32233266840784564,0.9217855830234595,0.6887550200803213,0.9893834550845746,1.0,31/181,15.05%,PRRX1;AR;BHLHE40;NFE2L2;MAPK14;DACT1;TCF7L2;NFATC1;TACC2;PIAS3;NCOA3;TRIP4;ZFPM2;TBX6;MDFIC;BEX1;HDAC3;NPM1;TCERG1;JUP;NCOR2;NCOR1;COMMD6;HDAC4;BBS4;DMAP1;KLF4;CTDP1;BCAS3;TTC8;SMARCA4
prerank,GTP binding (GO:0005525),0.32140042372796873,0.9210339299267343,0.6844758064516129,0.9883654911271844,1.0,55/172,27.93%,RAB32;RAB6A;GTPBP4;RAP1B;ARF4;SCG5;RIT2;DYNC1LI1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;RRAD;TUBD1;RHOA;RRAGD;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;ARL8A;NOA1;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;TSR1;RAP2B
prerank,nucleoside-diphosphatase activity (GO:0017110),0.44126425375264977,0.9207992397983701,0.5763411279229711,0.9860227879352598,1.0,4/12,18.58%,ENTPD2;NUDT5;CANT1;ENTPD6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3461343841630341,0.920734076914767,0.584070796460177,0.9832888084856243,1.0,6/53,5.23%,SLC1A5;SLC1A7;SLC7A6;SLC1A6;SLC47A1;SLC43A2
prerank,single-stranded DNA binding (GO:0003697),0.3306649750032198,0.918697665430655,0.6548117154811716,0.9847772650892332,1.0,19/93,18.32%,POLR2H;HNRNPA1;CTC1;RAD51B;RAD23B;IGHMBP2;HMCES;SAMHD1;MCM3;MAPT;ERCC4;POLR2D;POLR2G;SMC6;DDX11;FAM111A;RNF138;ERCC5;BLM
prerank,syntaxin binding (GO:0019905),0.3428487526868229,0.9182319842429383,0.6136363636363636,0.9829592904507515,1.0,25/61,27.17%,SYT2;SYT12;SCFD2;VPS52;VAMP1;ABCA1;SCFD1;SNAP23;NAPA;SNAP25;SNAP47;NSF;NAPG;SNPH;SYT1;VPS11;VAMP2;NAPB;STX16;STXBP5L;BAIAP3;STX7;SYT6;STXBP4;VAMP3
prerank,fatty acid synthase activity (GO:0004312),-0.35847657908285424,-0.9163420943102328,0.5472972972972973,0.7641517773811456,1.0,5/10,18.85%,ELOVL7;CBR4;ELOVL1;ELOVL4;OXSM
prerank,sodium:proton antiporter activity (GO:0015385),0.45099225270324966,0.915541259643402,0.6057142857142858,0.9862223101909183,1.0,4/11,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,voltage-gated anion channel activity (GO:0008308),-0.3271034968642533,-0.9147391073223929,0.5847457627118644,0.7599980072155664,1.0,6/15,17.09%,VDAC3;ANO1;CLCN2;GPR89B;GPR89A;CLCN1
prerank,nuclease activity (GO:0004518),0.34786672645652544,0.9136413738323967,0.6168122270742358,0.9876780892640248,1.0,16/52,25.15%,DIS3L2;ANG;RNASE4;N4BP2;SAMHD1;RNASE6;DNA2;ZC3H12A;DNASE1L2;NME1;ERCC5;OGG1;MAP1S;DFFB;DNASE1L1;RNASE1
prerank,small GTPase binding (GO:0031267),0.3177702552436191,0.9082217028539021,0.7203219315895373,0.9972012781298425,1.0,45/170,20.46%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;ULK1;TRIOBP;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5;STK19;EXOC4;DOCK4;FLNA;RNF41
prerank,GTPase binding (GO:0051020),0.31636825736648866,0.9054907982848546,0.735678391959799,1.0,1.0,66/195,25.79%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;RADIL;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;RRAGD;GNB1;ULK1;TRIOBP;HSP90AA1;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;SPTBN1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5;EPRS1;STK19;AIMP1;EXOC4;DOCK4;RASA1;FLNA;RNF41;ATG16L1;SIKE1;LZTR1;ANKFY1;ATG14;RAB11FIP3;PDE6D;ALS2;TSC2;RABGGTB;RAB29;CYFIP1;MAPKAP1
prerank,NADPH binding (GO:0070402),-0.341741623739922,-0.9047785440138915,0.612,0.7739652930271711,1.0,9/13,28.62%,HMGCR;QDPR;CBR4;NDOR1;LBR;DECR1;CBR3;GRHPR;KCNAB1
prerank,ubiquitin protein ligase binding (GO:0031625),0.31153385930858163,0.9036187023260411,0.7437437437437437,1.0,1.0,75/254,28.16%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;FOXO1;SCAMP3;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;TRAF5;BAG5;RELA;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,solute:anion antiporter activity (GO:0140323),0.42073391857734915,0.9030834904642644,0.609271523178808,0.9999375984389665,1.0,4/14,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC26A6
prerank,alpha-tubulin binding (GO:0043014),0.3623018454396463,0.9022826274158146,0.6186540731995277,0.9989018732739984,1.0,7/31,14.55%,FYN;DLEC1;HDAC6;TBCEL;SETD2;BBS4;INO80
prerank,N-acyltransferase activity (GO:0016410),0.3619527305657276,0.9015567203382949,0.6188235294117647,0.9975678482226191,1.0,7/32,18.79%,CERS6;PLAAT1;GNPNAT1;NAT8;PLA2G4E;SAT1;NAA50
prerank,outward rectifier potassium channel activity (GO:0015271),0.4431107132637671,0.9000792665586057,0.603399433427762,0.9979526894246622,1.0,3/11,7.85%,KCNT2;KCND1;PKD2
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.30981183409377927,0.8997955812630714,0.7497497497497497,0.995799185286607,1.0,79/269,28.16%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;ITCH;FOXO1;SCAMP3;TRIP4;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;STAT2;TRAF5;BAG5;RELA;STAM;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,cation:chloride symporter activity (GO:0015377),-0.3650762080858202,-0.8992831123346007,0.5396825396825397,0.7782840929490498,1.0,3/10,3.01%,SLC12A7;SLC12A2;SLC6A1
prerank,calcium channel regulator activity (GO:0005246),0.3612223791088366,0.8988975622635642,0.6252900232018561,0.994969345331435,1.0,9/37,14.84%,SGK3;TNNI3;SRI;STIMATE;YWHAE;MCUB;RRAD;CALM2;GEM
prerank,protein kinase regulator activity (GO:0019887),0.3268806887018099,0.8986275938455998,0.6879505664263645,0.9928500586774964,1.0,23/95,19.27%,CCNL2;FGF13;TAOK3;PPP1R1B;CXCL10;GPRC5D;STRADA;GSKIP;ELP4;NPM1;KIDINS220;CCNC;SMCR8;CDKN1A;CCND1;CCNH;CCNQ;MADD;NCK1;QARS1;GMFB;PRKAR2A;DUS2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44771906841489173,0.8957061265801342,0.6130790190735694,0.9964933685813393,1.0,1/10,2.22%,B4GALT1
prerank,ephrin receptor binding (GO:0046875),0.3797720991289347,0.8950356640994074,0.6240786240786241,0.995059385129054,1.0,4/21,6.81%,EFNA5;FYN;ANKS1B;SRC
prerank,tRNA binding (GO:0000049),0.3465488659033172,0.8939407907110004,0.6508287292817679,0.9945281291701129,1.0,14/43,21.87%,IGHMBP2;DALRD3;MRPS27;YRDC;SARS2;PSTK;ELP1;TRMT10B;TYW5;AIMP1;PTCD1;XPOT;NEMF;EIF2A
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3086904153570802,0.8931897165996976,0.7625250501002004,0.9933722172464821,1.0,79/232,26.47%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;CBX4;RNF121;PIAS3;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;UFL1;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;NSMCE2;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;RNF167;PRPF19;MUL1
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.39357687975920214,0.892454386469166,0.6188055908513341,0.9920349319231168,1.0,8/17,31.01%,NME2;CMPK2;NME1;AK8;AK9;NME6;AK5;AK3
prerank,hyaluronic acid binding (GO:0005540),0.43540519973373587,0.8912659567273472,0.6364942528735632,0.9917877641467857,1.0,2/10,6.64%,CD44;C1QBP
prerank,microtubule motor activity (GO:0003777),0.34270447563887063,0.8912610080372592,0.6601092896174864,0.9890766035020423,1.0,14/51,21.55%,KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;KIF3B;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,thioesterase binding (GO:0031996),0.43387569424029965,0.890275696051846,0.6394366197183099,0.9885015464858972,1.0,6/11,30.45%,ARF6;TRAF3;TRAF4;TRAF5;RAC1;TRAF6
prerank,nuclear receptor binding (GO:0016922),0.316010959305146,0.8899037445273055,0.7139938712972421,0.9865704672799943,1.0,41/111,27.20%,ESR1;FOXP1;TCF7L2;TACC2;PRMT2;NCOA3;TRIP4;GAS2L1;MED24;JUP;NCOR2;MED13;NCOR1;DCAF13;BCAS3;SMARCA4;RNF14;TRIM68;STAT5B;DDX5;PADI2;NRIP1;JMJD1C;NSD1;THRAP3;TMF1;RNF6;BAZ2A;NCOA2;KDM4C;NCOA6;LATS1;LCOR;CALR;ASXL1;KDM3A;BRD8;PRPF6;GRIP1;ARID1A;MMS19
prerank,Hsp90 protein binding (GO:0051879),0.3564217855862475,0.8880143508142144,0.6212471131639723,0.9877741824739669,1.0,16/33,30.69%,HDAC6;STUB1;PPP5C;ERN1;MAPT;PPEF2;CHORDC1;AHSA1;USP19;NR3C1;TSC2;UNC45A;TSC1;HDAC8;HSF1;TELO2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.35199183627613395,0.8865855560736946,0.6443661971830986,0.9878658423967347,1.0,9/35,20.37%,SMPD3;PLCE1;PLCB4;PDE11A;MPPE1;PDIA3;SMPD1;GPLD1;GDPD3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3873090197295862,0.8854419498952263,0.6291718170580964,0.9875138629430115,1.0,5/20,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.4047738052609864,0.8843457431336639,0.6431322207958922,0.9844631401120305,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,intracellular chloride channel activity (GO:0061778),0.4047738052609864,0.8843457431336639,0.6431322207958922,0.9844631401120305,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,NADP binding (GO:0050661),-0.24775816776631013,-0.8828315402802137,0.7077922077922078,0.8054725626580888,1.0,16/32,22.17%,GMDS;DPYD;NOS3;HMGCR;QDPR;CBR4;NOS1;SPR;NDOR1;CRYZL1;DHCR7;LBR;DECR1;CBR3;TM7SF2;HSD11B1
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.36686080849362745,0.8816547438711102,0.6475609756097561,0.9870703759123233,1.0,6/28,18.54%,RPS6KA2;MAPK14;MAP2K3;AKT1;MAP2K2;MAP2K4
prerank,phosphatidic acid binding (GO:0070300),0.3846652660985012,0.8779665871147084,0.6384615384615384,0.9917367430092816,1.0,2/19,1.06%,SESTD1;SMPD3
prerank,phosphatase activity (GO:0016791),0.32361935337664655,0.8762007331047722,0.6800847457627118,0.9925301092653993,1.0,23/73,23.47%,PLPP3;ACP2;PTPRJ;PLPP5;PLPP1;NT5M;BPNT2;OCRL;PPP5C;DUSP11;NUDT16L1;INPP5K;NUDT16;PGAM5;PLPPR3;PHOSPHO2;PPP1CC;PLPP2;ACP3;LPIN3;CILP;ACP6;LHPP
prerank,protein phosphatase 2A binding (GO:0051721),-0.27848043376099063,-0.8760180221763413,0.648936170212766,0.8115975722411836,1.0,5/23,4.14%,CTTNBP2NL;STRN3;DAB2IP;STRN;BOD1L1
prerank,CARD domain binding (GO:0050700),-0.3212476632546436,-0.8738961442322849,0.6228813559322034,0.8081620329736057,1.0,9/14,27.67%,CASP4;MAVS;NOD1;CARD19;IRGM;NOD2;RIPK2;CASP1;CARD14
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3148884670676646,0.8738267891265699,0.722680412371134,0.9947062057468194,1.0,24/100,19.61%,NCF4;SESTD1;GAP43;MYO10;PLEKHF1;ATG2B;CLVS2;ARHGAP9;IQGAP1;WIPI2;PLEKHA4;WDR45B;PLEKHB2;SNX21;AKT1;MAPT;ATG2A;DENND1A;PLA2G4E;OGT;ARAP1;ANXA8;BBS5;CLVS1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4220253710091182,0.8704139368467414,0.6498599439775911,0.9988329835265914,1.0,4/12,20.22%,PSEN1;SPPL2B;NAPSA;BACE1
prerank,transcription cis-regulatory region binding (GO:0000976),0.3000739233805087,0.8698271197031838,0.864,0.9972391649718443,1.0,61/406,16.80%,LMX1A;AR;LHX8;TRPS1;BNC2;WT1;SCRT2;HSF2;PBX1;FOXP1;GLIS2;RUNX1;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SOX10;FOXK2;JUND;TCF7L2;RBAK;CREB3L1;NR1D1;CREBZF;MTF1;FOXC2;AGO2;SOX5;SMAD6;RNF10;SATB2;BRD7;ZNF3;NPM1;MZF1;CEBPB;GLI3;XRCC5;DR1;ATF1;PEG3;NCOR1;IKZF5;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;KLF4;MLXIP;NR2C2;E2F3;CDK5RAP2;ZBTB5;PER1;SNAI2;CHD3;E4F1;TFAP4
prerank,transmitter-gated ion channel activity (GO:0022824),0.3546001451157524,0.8693912695907982,0.6571428571428571,0.9954426954854934,1.0,13/29,30.12%,GRIN2D;GRIA2;GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GLRA3;GABRA3;GRID2;GABRA1;GLRA2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.41988622157596694,0.8678816114518552,0.6600846262341326,0.9957063938508511,1.0,4/12,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3139043263196083,-0.8677227270557998,0.6553191489361702,0.8125082414494685,1.0,11/15,43.93%,COX4I1;NDUFA4;COX5A;NDUFA4L2;COX4I2;COX6B1;COX6A1;COX7A1;COX5B;COX6A2;COX8A
prerank,acyl-CoA hydrolase activity (GO:0047617),0.387727151287223,0.8675357056874469,0.6338939197930142,0.9937626931034126,1.0,3/17,14.25%,ACOT6;ACOT9;ACOT1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.4197401032460051,0.8665257916736365,0.6704384724186704,0.9931012387716748,1.0,4/10,21.58%,SETD2;SETD5;PRDM9;NSD1
prerank,PDZ domain binding (GO:0030165),0.3238086688663949,0.8664907954032701,0.689989235737352,0.9905865939331038,1.0,22/61,21.82%,CCDC88C;DLG4;ATP2B4;GNG12;FZD7;PSEN1;SLC26A6;TBC1D10A;KIDINS220;PLEKHA1;CRIPT;FZD4;MAP2K2;ACOX1;NSF;SDC2;ATP2B1;SNTG2;CIT;DOCK4;PTEN;SRR
prerank,ion channel activity (GO:0005216),0.31810519758959654,0.8652851675728459,0.7056323060573858,0.9902763841172508,1.0,23/80,25.89%,PIEZO2;TRPV3;GRIN3A;TMEM63A;GRIN2D;PKD2;GRIA2;CNGB1;MCUB;TMEM120A;CALHM2;GRID1;GRIN2A;CHRNA7;TMC3;CHRNA5;GRIA3;GRIK5;GRIK2;TRPC1;GRIK4;ANXA6;TRPV2
prerank,ATPase regulator activity (GO:0060590),0.333510552338797,0.8642506405259329,0.6749716874292185,0.9896599593862576,1.0,14/38,29.78%,TOR1AIP2;DNAJA2;GRPEL2;DNAJB2;BAG4;AHSA1;DNAJB1;BAG3;BAG5;HSPH1;TSC1;DNAJA1;FNIP1;DNAJC1
prerank,hydro-lyase activity (GO:0016836),0.334388455617022,0.8637069959810616,0.6716417910447762,0.9881102922162328,1.0,6/41,15.31%,EHHADH;CYP2S1;AUH;ACO2;CDYL;HACD3
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4196297058659153,0.8634270084341402,0.6629986244841816,0.9860276381581928,1.0,3/11,12.80%,EGFR;MAP3K6;TAOK2
prerank,ubiquitin protein ligase activity (GO:0061630),0.29788298638267635,0.8617246711724057,0.8246492985971944,0.98662583949259,1.0,76/228,26.47%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;MUL1
prerank,potassium ion antiporter activity (GO:0022821),-0.3068201579497778,-0.8609704803939013,0.6612244897959184,0.8179986655519716,1.0,2/15,2.49%,SLC24A3;SLC9A2
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3590365862729337,0.860779169548293,0.6698911729141476,0.9857179823868827,1.0,11/24,29.99%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;YKT6;ZDHHC15;GOLGA7B
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.3491160666732565,0.8590064218076187,0.6985210466439136,0.9865595355686606,1.0,16/35,29.85%,FOXP1;AGO2;NPM1;UBTF;DR1;SMARCA4;RRN3;BAZ2A;TBP;NR3C1;RELA;KLF10;SNAPC3;AGO1;TP53;FOS
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.29983293781876136,0.8551006680141728,0.81067472306143,0.9913824688716855,1.0,36/188,18.74%,AR;BNC2;WT1;PBX1;GLIS2;RUNX1;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;JUND;TCF7L2;CREB3L1;NR1D1;CREBZF;FOXC2;SOX5;SMAD6;RNF10;BRD7;MZF1;CEBPB;XRCC5;NCOR1;SIX1;HDAC4;KLF4;CDK5RAP2;PER1;CHD3;TFAP4;ZBED4;CTCF;KCNH2;PRDM9
prerank,protein kinase activator activity (GO:0030295),0.3227393963386021,0.8550675638598155,0.7301414581066377,0.9888998697587986,1.0,13/60,15.90%,FGF13;ETAA1;GPRC5D;GAS6;STRADA;ABI1;IQGAP1;CALM2;CDKN1A;DBF4;STK3;MAP2K2;MADD
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2581635410246996,-0.8543663170805559,0.6832298136645962,0.8233504530212641,1.0,8/27,14.62%,SIAH2;PPARA;UBE3D;RNF144B;DCUN1D4;RNF180;DCUN1D3;SIAH3
prerank,poly(U) RNA binding (GO:0008266),0.36567194244958423,0.8479066116418729,0.6756410256410257,0.9996201636907581,1.0,3/20,10.62%,DIS3L2;RBMS3;HNRNPH1
prerank,lipoprotein particle receptor binding (GO:0070325),0.3510673539833149,0.8477582511726642,0.683252427184466,0.9973422908481786,1.0,7/27,27.79%,LRP1;CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,carboxylic acid binding (GO:0031406),0.3322523166805857,0.8468453363508666,0.6969001148105626,0.9964085591277972,1.0,10/38,22.64%,GCLC;GRIN3A;SESN3;GLUD1;EPDR1;GLDC;CASTOR2;SRR;SESN2;UBR2
prerank,actin monomer binding (GO:0003785),0.3608940057748432,0.8467093447532993,0.6873479318734793,0.9941453628281646,1.0,4/22,10.26%,COBL;PFN2;ABL2;TWF1
prerank,chloride channel inhibitor activity (GO:0019869),0.4178261166797253,0.8449950619733445,0.6685472496473907,0.9946398188149435,1.0,7/10,34.05%,STX1A;WNK2;STX7;CFTR;STX8;VAMP8;WNK3
prerank,Tat protein binding (GO:0030957),0.4230109949515042,0.8433542774017326,0.6732954545454546,0.9950722337403047,1.0,4/10,15.05%,MDFIC;NPM1;CTDP1;SMARCA4
prerank,thyroid hormone receptor binding (GO:0046966),0.34405898887182135,0.8424658986093496,0.6928571428571428,0.994215465415126,1.0,10/28,23.79%,PRMT2;NCOA3;GAS2L1;MED24;MED13;NCOR1;JMJD1C;NSD1;THRAP3;NCOA6
prerank,steroid hydroxylase activity (GO:0008395),0.38327429675036156,0.8396978265611825,0.6836086404066074,0.9966860190431939,1.0,1/16,1.39%,CYP2S1
prerank,metal ion:proton antiporter activity (GO:0051139),0.39748396675505987,0.838805314837819,0.6794520547945205,0.9957506954650198,1.0,4/13,15.88%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.30489159422939016,0.8380185327759776,0.7444326617179216,0.9945866690125613,1.0,19/74,19.35%,PAPSS2;DGKQ;PIK3C2B;MVK;CHKB;GK5;PIK3CA;GALK1;AGK;PGM2L1;PI4KB;PANK1;PI4KA;PKM;IPPK;TRPT1;GNE;PANK3;DCAKD
prerank,3'-5' exonuclease activity (GO:0008408),0.32178094083275094,0.836760789440564,0.7078142695356738,0.9942713688480855,1.0,6/45,12.48%,REV3L;DIS3L2;ERI3;EXOSC7;RAD1;REXO2
prerank,cysteine-type peptidase activity (GO:0008234),0.30691281039030377,0.8344127541351019,0.7484076433121019,0.995805533613427,1.0,13/73,15.82%,UCHL1;CAPN2;USP36;USP10;USP29;USP26;USP33;OTUD7B;USP48;USP50;USP5;USP7;PDIA3
prerank,mRNA methyltransferase activity (GO:0008174),0.4035440686908734,0.8338998043198145,0.6879334257975035,0.9941843071209387,1.0,4/12,22.63%,TRMT61A;CMTR2;PCIF1;RNMT
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3333312542714273,0.8332426172880162,0.6972909305064782,0.9928532267234196,1.0,2/32,5.23%,SLC1A5;SLC43A2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3131779001433766,0.83317619442539,0.7439024390243902,0.9905096779666278,1.0,14/54,20.07%,HDAC9;HDAC6;SIRT2;HDAC3;GLS2;GLS;NIT2;HDAC4;NGLY1;NTAN1;ASRGL1;SUDS3;NIT1;MIER1
prerank,gamma-tubulin binding (GO:0043015),0.35559099027814534,0.8320359596440746,0.6816479400749064,0.9901308191764094,1.0,7/21,29.50%,RAB11FIP5;BLOC1S2;CDK5RAP2;TUBGCP5;RAD51D;ARHGEF7;TUBGCP3
prerank,protein kinase C activity (GO:0004697),-0.3023593776153377,-0.830681267472831,0.6833333333333333,0.8608265934930001,1.0,4/14,8.79%,PRKCH;PRKD1;PRKCE;PRKCQ
prerank,peptide hormone receptor binding (GO:0051428),0.40111939426226173,0.8299834971218124,0.6826516220028209,0.991103443423531,1.0,1/11,7.34%,ADCYAP1
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3409220398576648,0.8297077624625738,0.7130647130647131,0.9891040956132052,1.0,11/28,30.03%,GABRG3;GRID1;CHRNA7;CHRNA5;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,muscle alpha-actinin binding (GO:0051371),0.3786324655126319,0.8295715253639935,0.6851119894598156,0.9868982684988217,1.0,5/15,19.64%,PDLIM7;PKD2;PDLIM1;PALLD;PDLIM2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.29332052964075295,0.8279356040988042,0.8082744702320888,0.9872796649566504,1.0,20/134,14.88%,SLCO2A1;SLC1A5;SLC25A21;SLC1A7;SLC26A5;SLC4A8;SLC25A25;SLC4A3;SLC6A8;SLC35B1;SLC26A6;SLC35D1;SLC2A10;SFXN1;SLC7A3;ABCC1;SLC23A1;SLC23A2;SLC15A4;SLC25A17
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3975682741602643,0.827388429577448,0.6801736613603473,0.9857536489560397,1.0,2/11,17.91%,CHRNA7;CHRNA5
prerank,anion channel activity (GO:0005253),0.3106569431281196,0.8263876356604003,0.7531914893617021,0.9850698176871907,1.0,11/61,19.26%,ANO3;LRRC8D;CLCN5;GABRR3;VDAC2;CLCC1;GABRG3;TTYH3;VDAC1;ANO5;GABRG2
prerank,glutamate receptor activity (GO:0008066),0.35724935360915244,0.8253506321484673,0.695,0.9844535328570447,1.0,9/19,27.38%,GRIN2D;GRIA2;GRID1;GRM1;GRIK5;GRIK2;GRIK4;GRM5;GRID2
prerank,ATPase activator activity (GO:0001671),0.34762855418039373,0.8235377924121732,0.7031446540880503,0.9850127930108299,1.0,5/20,21.23%,TOR1AIP2;DNAJA2;DNAJB2;AHSA1;DNAJB1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3416273291751578,0.82299755132061,0.7185273159144893,0.9835329466562789,1.0,9/27,18.07%,SLC4A8;ATP2B4;SLC11A2;SLC23A1;SLC8A2;CNNM4;TUSC3;TMEM165;ATP2B1
prerank,histone acetyltransferase activity (GO:0004402),0.3319241738280363,0.8228088402201347,0.7045977011494253,0.9815027070887445,1.0,12/30,25.20%,NCOA3;MCM3AP;KAT2B;KAT14;SRCAP;USP22;NAA50;ARRB1;KAT6B;BAZ1A;KAT5;KAT7
prerank,magnesium ion binding (GO:0000287),0.2925874913446691,0.8222507055877007,0.8296146044624746,0.9800878272278875,1.0,44/135,28.99%,GCLC;MAPK12;DIS3L2;IRAK3;FOXK2;MVK;IDH1;EYA2;ABL2;UBA2;ERN1;DYRK2;MAP3K6;NUDT16;CERK;FAN1;STK3;GEM;NUDT5;NME1;ADPRH;STK38;RP2;IDH3G;OXSR1;STK26;XYLT2;SRPK1;SRR;PI4K2A;MTHFD2;ADCY2;LATS1;MARK2;XXYLT1;MAST2;PLSCR3;PPA1;MSH6;PSPH;DUT;PGP;HMGCL;PPA2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4137027871701292,0.8192552007267734,0.711484593837535,0.9824177488182865,1.0,4/10,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,DNA binding (GO:0003677),0.2778768831774042,0.814480249483924,0.976,0.9878324717761164,1.0,126/694,18.74%,MPG;FOXP2;IRF4;EGFR;POLR2H;C1D;WT1;MEOX2;HNRNPA1;ANG;HIVEP2;TSHZ2;CTC1;PBX1;KLF12;TRNP1;TIPIN;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;KLF2;RAD51B;MAFF;TCF7L2;COLEC11;HOXA5;RAD23B;MEIS2;FOXO1;JRKL;NFIB;MND1;CREBZF;TARDBP;IGHMBP2;CGAS;MLXIPL;MTF1;AIFM2;GLI2;TBX6;FOXL1;PHF1;MSL3;HMCES;SOX8;SPTY2D1;VDR;NR6A1;FOXC2;SYCP2;DNASE2;CDK9;RYBP;SAMHD1;POLG2;MCM3;ZNF3;CHD2;SMC1A;CSRNP3;BCL6;CEBPB;MAPT;SLPI;ERCC3;RAD1;ERCC4;CCDC25;FAN1;XRCC5;GTF3C2;LIN9;KDM5B;QRICH1;POLR2D;POLR2G;DDB1;TERF1;DNA2;CR2;BRIP1;SMC6;SIX1;DDX11;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;FANCG;PLAGL2;NBN;HOXA7;INO80;POU3F2;FAM111A;DNASE1L2;SMARCA4;CHD8;NUPR1;NR2C2;RPL6;E2F3;HMGB3;CENPC;PSIP1;SNAI2;CHD3;BCLAF3;RNF138;TFAP4;NUFIP1;ILF2;RAD50;ERCC5;RBM6;BLM;POLD1;SUPV3L1;TINF2;CTCF;PRDM9
prerank,MAP-kinase scaffold activity (GO:0005078),0.3951766799003241,0.8138432311433648,0.7186629526462396,0.9864594352234215,1.0,3/11,15.60%,AKAP13;IQGAP1;MAP2K2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.3646114117585604,0.8129218893113843,0.7022106631989596,0.9832251720443906,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.3646114117585604,0.8129218893113843,0.7022106631989596,0.9832251720443906,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,exoribonuclease activity (GO:0004532),0.3792390811590581,0.811047373948635,0.7115384615384616,0.9836848514473238,1.0,3/12,14.15%,EXOSC7;ZC3H12A;EXOSC1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3441226552880623,0.8107385719049482,0.7269417475728155,0.9818500799936916,1.0,6/22,16.13%,ATP6V0A2;ATP6V1E1;ATP2A2;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.3992694969164256,0.8104362386381653,0.7262723521320495,0.9800146731206676,1.0,4/11,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,signaling receptor complex adaptor activity (GO:0030159),0.31733862728419393,0.8101882000185373,0.7456846950517837,0.9781463383124896,1.0,4/38,6.28%,IRS1;AXIN1;SPATA2;SH2B1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.30599889291427385,-0.8070195774053974,0.6900826446280992,0.895413161640631,1.0,5/12,19.45%,CASP8AP2;BCL2L13;ATP2A3;NOD1;CTSH
prerank,amino acid binding (GO:0016597),0.3263472877916651,0.8068256422362297,0.736046511627907,0.9811452789242353,1.0,2/31,5.10%,GCLC;GRIN3A
prerank,calcium channel inhibitor activity (GO:0019855),-0.32253683661092497,-0.8055208767990539,0.7045454545454546,0.8903321239621765,1.0,1/11,0.06%,ITPR1
prerank,cadherin binding (GO:0045296),0.2756559414684036,0.8038533628964244,0.922,0.9834046480322272,1.0,82/315,22.80%,DBN1;CDH26;AHNAK;EGFR;ANXA1;PFKP;PKP3;ANXA2;DIAPH3;HDLBP;STX5;MPP7;SPTAN1;ACVR1;PTPRJ;PPL;IDH1;SRC;FSCN1;SNX1;CAST;SLK;ABI1;FXYD5;USO1;YWHAE;SH3GL1;PSEN1;IQGAP1;PDXDC1;CDH22;TWF1;MAPRE1;PAICS;ZC3HAV1;TBC1D10A;PDLIM1;VASN;JUP;FLNB;SFN;LARP1;SCYL1;ATXN2L;CBL;STK24;CTNND2;ARGLU1;EIF3E;TNKS1BP1;GIPC1;EVPL;PI4KA;RSL1D1;RPL6;PKM;SPTBN1;EPS8L2;NCK1;EEF1G;AHSA1;CKAP5;SHTN1;PUF60;STK38;LASP1;ALDOA;UBFD1;LDHA;FLNA;RAB10;ATIC;CCS;DNAJB1;CTNNA3;EIF2A;CTTN;YWHAB;PLEC;SEPTIN9;BAG3;PACSIN2
prerank,phosphatase activator activity (GO:0019211),0.3780946146600962,0.8018012327246336,0.7264276228419655,0.9843408615347334,1.0,4/14,17.06%,B3GAT3;CALM2;GTF2F1;PPP2R5B
prerank,ADP binding (GO:0043531),0.33161329680617824,0.7975839532899657,0.7479191438763377,0.9883627498470828,1.0,4/25,10.24%,GCLC;MYO9B;PPP5C;ERN1
prerank,cation channel activity (GO:0005261),0.2896395542973725,0.7967495971076043,0.828838174273859,0.9872925141167724,1.0,11/94,10.51%,KCNK5;PIEZO2;ANXA2;PKD1;TRPV3;TMEM63A;PKD2;MCU;PSEN1;KCNK9;KCNA2
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.34411197877435123,0.7960526533835214,0.7564259485924113,0.9860452248993878,1.0,2/23,4.67%,PLCE1;PLCB4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3804028545241868,0.7953810884863093,0.7311827956989247,0.9847741772161925,1.0,2/11,20.40%,PADI2;DDAH2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.32537626445669166,0.7934479168963557,0.7526627218934911,0.985460973207275,1.0,6/30,12.21%,CARD16;GAS6;CAST;DPEP1;CSTB;CD27
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.3000606050141486,0.7927535305856097,0.7786177105831533,0.9841948367377643,1.0,20/55,26.25%,ANXA2;PKD1;TRPV3;ATP2B4;PKD2;MCU;PSEN1;ATP2A2;SLC8A2;SEC61A1;TMEM165;CHRNA7;ATP2B1;CUL5;TRPC1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.30301687729032734,0.7921952653765282,0.7827050997782705,0.9827180977861084,1.0,10/51,16.78%,SLCO2A1;SLC35E3;MCU;SLC25A16;SLC16A10;SLC4A4;SLC35D1;SLC25A3;SLC35E1;SLC20A1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3384744114614431,0.7908029562353479,0.7533908754623921,0.982509785673132,1.0,4/22,10.44%,ZRANB1;ZBTB1;OTUD7B;SQSTM1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3489520165728557,0.7897759960474385,0.7422279792746114,0.9819097457540455,1.0,4/17,16.56%,BLVRB;TECR;PTGR1;BDH2
prerank,ion channel inhibitor activity (GO:0008200),0.317451732122003,0.7892091950789484,0.7694954128440367,0.9804751340808969,1.0,6/35,12.62%,KCNV1;TNNI3;STX1A;CAMK2D;MCUB;CALM2
prerank,protein phosphatase regulator activity (GO:0019888),0.29779284101809916,0.7877024052851335,0.7917570498915402,0.9803403358835792,1.0,14/53,19.23%,PPP1R1B;PPP6R2;RCAN3;B3GAT3;RCAN1;SAG;SHOC2;CALM2;MGAT5;PPP2R1B;PPP2R5B;PPP1R9B;SET;PPP2R2A
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.37094160266088383,0.7866709562632179,0.7554945054945055,0.9796200159007102,1.0,3/13,15.00%,FAN1;DNA2;DNASE1L2
prerank,lysine N-methyltransferase activity (GO:0016278),0.34024759660631665,0.7856608286505492,0.7484811664641555,0.9788606993941773,1.0,7/20,26.78%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;EEF1AKMT3;KMT5A
prerank,kinase activator activity (GO:0019209),-0.2301560020832138,-0.7828296888089846,0.8333333333333334,0.9196153880012693,1.0,4/30,6.56%,PRKAG2;GPRC5C;RPTOR;RGCC
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.343704866577943,0.7810281892991967,0.7630573248407644,0.9830633716753421,1.0,9/19,30.03%,GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.3826657550552977,0.7809055301883188,0.7313642756680732,0.9810202614960795,1.0,1/11,1.41%,WT1
prerank,voltage-gated calcium channel activity (GO:0005245),0.30870310866310874,0.7765082108933893,0.7694954128440367,0.9850490574469226,1.0,8/37,18.37%,CACNA2D2;PKD2;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;NCS1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.31185604759728847,0.7761498559191883,0.7849462365591398,0.9833412027897942,1.0,4/33,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,retinoic acid receptor binding (GO:0042974),0.34457067328919344,0.7728228993739633,0.7735099337748345,0.9856823483891309,1.0,7/17,25.84%,PRMT2;VDR;NRIP1;NSD1;NCOA6;ASXL1;RARG
prerank,nucleosomal DNA binding (GO:0031492),-0.24494000830722057,-0.7722389200896687,0.8146067415730337,0.9285005608321995,1.0,5/21,14.06%,H3-3A;CHD4;ACTB;MTA2;SMARCB1
prerank,acetylcholine receptor activity (GO:0015464),0.32724483365336066,0.7715110416930152,0.7681874229346486,0.9853672309394539,1.0,3/22,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,transaminase activity (GO:0008483),0.3748655080224893,0.7694290203586518,0.7668539325842697,0.986045138956436,1.0,3/11,20.58%,BCAT1;PSAT1;GOT1
prerank,estrogen receptor binding (GO:0030331),0.30758918268154656,0.7687385988547368,0.7864768683274022,0.9848918955949764,1.0,10/32,24.39%,ESR1;PRMT2;TRIP4;DCAF13;PADI2;NRIP1;NSD1;NCOA6;LATS1;LCOR
prerank,H4 histone acetyltransferase activity (GO:0010485),0.3806520478120896,0.7673208428719552,0.7595473833097596,0.9846285637177955,1.0,3/10,18.79%,MSL3;USP22;NAA50
prerank,nucleotidase activity (GO:0008252),0.3511444237290529,0.7639900313922148,0.7612137203166227,0.9867648908222526,1.0,4/15,21.18%,NT5M;BPNT2;ACP3;NT5DC2
prerank,four-way junction DNA binding (GO:0000400),0.34456341892408926,0.7612376063455879,0.7759699624530664,0.988175795550973,1.0,7/17,27.43%,XRCC3;RAD51B;HMGB3;BLM;RAD51D;MSH6;MEN1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.37208781028410415,0.760339698867048,0.7798295454545454,0.9871687303869516,1.0,2/11,14.88%,SLC25A25;SLC25A17
prerank,neuropeptide binding (GO:0042923),-0.25868166708875606,-0.7579049984145589,0.8538812785388128,0.9414005134333376,1.0,10/18,40.47%,SORL1;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,glutathione transferase activity (GO:0004364),-0.23875315146499154,-0.7566776767872175,0.8571428571428571,0.9351879138977609,1.0,8/23,26.35%,LANCL1;GSTA4;MGST1;GSTA3;MGST3;GSTO1;GSTT2;GSTK1
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2761784711215699,0.7559985772282624,0.8692468619246861,0.9907803007223602,1.0,11/85,20.37%,MGLL;CEL;PLAAT1;LCAT;PON3;APMAP;DAGLB;PLA2G4E;PTRH2;LIPC;GDPD3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.28840412649598995,0.7553233218000455,0.8366445916114791,0.9894874193294689,1.0,15/49,25.50%,ZRANB1;RAD23B;HDAC6;ZBTB1;OTUD7B;SQSTM1;TNIP1;ABRAXAS1;FAAP20;TAB2;TNIP2;UBQLN4;PSMD4;AGAP3;UFD1
prerank,calcium channel activity (GO:0005262),0.27651945147667756,0.7548221136234057,0.854602510460251,0.9879442407174339,1.0,23/84,26.25%,CACNA2D2;ANXA2;PKD1;TRPV3;PKD2;MCU;PSEN1;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;SEC61A1;CHRNA7;NCS1;CUL5;TRPC1;CACNA2D1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.33421182361403223,0.7547440139388125,0.7865459249676585,0.9858777005757444,1.0,7/18,24.70%,TGFBR2;ACVR1;AMHR2;TGFBR1;ACVR2A;BMPR1A;ACVR1B
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3730433753184346,0.7517993277239183,0.7839771101573677,0.9875676482413707,1.0,2/10,8.49%,PIK3C2B;PIK3CA
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.2945209755330895,-0.7517422421661393,0.7582781456953642,0.934643211368356,1.0,2/11,10.39%,KCND3;KCNQ1
prerank,hexose transmembrane transporter activity (GO:0015149),0.3557739123189584,0.7509494405782692,0.7589403973509934,0.9864895380070929,1.0,1/12,2.06%,MFSD4A
prerank,voltage-gated sodium channel activity (GO:0005248),0.31544659470382697,0.7494636495387597,0.8035487959442332,0.9862497694530292,1.0,11/22,35.52%,PKD2;HCN4;SCN4B;HCN1;SCN9A;SCN2A;CACNA1H;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,phospholipid transfer activity (GO:0120014),0.3225289920972315,0.7484576498759009,0.7695262483994878,0.9853812803829012,1.0,6/21,20.35%,TRIAP1;OSBPL2;PRELID3A;GLTP;PITPNM1;PRELID1
prerank,cyclic nucleotide binding (GO:0030551),0.3203876219355562,0.7466013954421882,0.7922885572139303,0.9855992492935581,1.0,5/21,11.90%,PDE11A;PDE10A;CNGB1;PDE4D;PDE5A
prerank,poly-pyrimidine tract binding (GO:0008187),0.3154114955326074,0.7460338651312486,0.8007566204287516,0.9842190040355597,1.0,3/23,10.62%,DIS3L2;RBMS3;HNRNPH1
prerank,histone acetyltransferase binding (GO:0035035),0.31608564139203355,0.7443447017275595,0.7960687960687961,0.9842208042244251,1.0,5/21,15.77%,TRIP4;SIRT2;GLI3;BCAS3;TRIM68
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.25559591595713954,0.7436893239711212,0.983983983983984,0.9829380137138597,1.0,128/431,28.87%,TNK1;PFKP;RAB32;RAB6A;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;GTPBP4;ACLY;RAP1B;MVK;ABCE1;IGHMBP2;ARF4;SCG5;TBCK;RIT2;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;DYNC1LI1;PPP5C;CLPX;GALK1;AKT3;RHOJ;ARF1;RHOQ;ERN1;TWF1;DYRK2;TUBB6;RAB2A;TARS1;NRAS;KRAS;AKT1;MAP3K6;SARS2;PNPLA8;GTPBP10;NUDT16;RRAD;TUBD1;PXK;RHOA;RRAGD;STK3;HSP90AA1;PEX1;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;CHD8;HSPA14;GLUD1;RND3;PMVK;HARS1;RAC3;PRPS1;PRPS1L1;RAB35;IDE;NME1;ABCF1;ABCB9;RAB1B;BLM;TGFBR1;STK38;PANK3;RRAS2;ABCD3;OXSR1;STK26;PIP4K2B;RALA;RAB10;BMPR1A;SRPK1;SRR;PI4K2A;ADSS2;MYO1F;TUBG2;KCNJ11;RABL3;LATS1;WNK2;ARL8A;NOA1;ACVR1B;MARK2;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;EIF4G1;MAST2;RND2;MSH6;RAP1A;NDUFA13;DIRAS2;P2RX4;TUBB2A;RHEBL1;PRPS2;TSR1;RAP2B;PRKCI;RPS6KA5;MYH10;PEAK1;BMPR1B;ATP5F1A;PTPA
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.25959429813425555,0.7431598724888596,0.9122098890010091,0.9815154723196827,1.0,36/147,20.73%,ARHGEF28;AKAP13;PLCE1;CCDC88C;RASGRF1;PREB;FARP2;RASGEF1A;FARP1;FRMD7;MYCBP2;RGL1;HPS4;ARHGEF10;RGL2;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;EEF1B2;MADD;EPS8L2;SOS1;ANKRD27;RCC1L;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;TIAM1;DENND4B;DENND2A
prerank,RNA cap binding (GO:0000339),0.33844157452030693,0.7427487536909245,0.7938931297709924,0.9798889635344263,1.0,8/16,28.38%,EIF4A1;AGO2;LARP1;EIF3D;NCBP3;CYFIP1;EIF4E2;LSM1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.35384823854330605,0.7423149379616184,0.7945945945945946,0.9783574025130772,1.0,3/13,14.58%,SLC7A6;SLC7A3;SLC15A4
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.3113082965170907,0.7399743698295083,0.8114558472553699,0.9791893730551666,1.0,7/25,21.13%,SESTD1;PLEKHA4;AKT1;PLEKHA1;PLA2G4E;ANXA8;GAB2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.29901917537319617,0.7396132936149846,0.8291571753986332,0.97756143452941,1.0,14/34,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;PRDM9;N6AMT1;EZH2;SETDB1;CAMKMT;EEF1AKMT3;KMT5A;MEN1;SUV39H1
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3095089418496034,0.7386287155243252,0.7971360381861575,0.9767026018504623,1.0,2/24,5.90%,SESTD1;PLEKHF1
prerank,NF-kappaB binding (GO:0051059),0.3139749650359261,0.7364032767207508,0.8246674727932285,0.9773000416016807,1.0,9/24,31.82%,HDAC3;NPM1;COMMD6;ANXA4;CPNE1;RELA;BCL10;BRMS1;CDK5RAP3
prerank,potassium channel regulator activity (GO:0015459),0.2778628520361254,0.7329308179892655,0.8512304250559284,0.9793735895582187,1.0,10/49,20.33%,KCNV1;SGK3;SGK2;YWHAE;AKT1;KCNAB3;CHP1;AKAP9;RASA1;FLNA
prerank,phosphatidylcholine transporter activity (GO:0008525),0.3265412857150782,0.732459191374727,0.8036649214659686,0.9779079445320995,1.0,2/17,7.00%,ATP8B1;ABCA1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.2707822651219265,-0.7316237186527382,0.819672131147541,0.9534535130489341,1.0,4/13,13.37%,PRKAR1B;KCNQ1;RYR2;PRKAR2B
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3373499607667332,0.7313196779940386,0.819918144611187,0.9772125357955179,1.0,3/14,18.73%,KCNJ2;KCNJ3;KCNH2
prerank,organic cation transmembrane transporter activity (GO:0015101),0.32930038384433824,0.7305217221330109,0.8067010309278351,0.9760975746522493,1.0,4/16,17.46%,SLC18A3;SLC44A1;SLC25A17;SLC44A2
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.34487273723426526,0.7250114129236551,0.8183060109289617,0.9806158773353248,1.0,2/12,4.40%,TGFBR2;ACVR1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.333343875496344,0.7220827272665257,0.8074277854195323,0.9820021603775643,1.0,2/12,8.96%,CDK4;CDK9
prerank,nuclear export signal receptor activity (GO:0005049),-0.2861585554605329,-0.7210617288889931,0.8254545454545454,0.9591872359970584,1.0,4/11,26.88%,XPO5;NUP214;XPO1;CSE1L
prerank,voltage-gated chloride channel activity (GO:0005247),0.350261706854365,0.7193869892241843,0.8036211699164345,0.9829280371451284,1.0,1/10,5.11%,CLCN5
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.34358439301035315,0.7193704302779064,0.8083333333333333,0.9809071605556746,1.0,2/12,14.88%,SLC25A25;SLC25A17
prerank,pseudouridine synthase activity (GO:0009982),0.337406571407841,0.7184778684099719,0.8241758241758241,0.9798633942186041,1.0,1/13,4.19%,RPUSD1
prerank,GTPase regulator activity (GO:0030695),0.24720130449293418,0.7156864572735309,0.9678714859437751,0.9809344885565889,1.0,30/212,10.24%,GPSM2;ARHGAP10;SGSM2;ARHGAP44;RABGAP1L;SLIT2;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;PREB;ARHGAP42;ADAP1;ASAP3;TBCK;MYO9B;FLCN;SEC23A;OCRL;ARHGAP9;GPSM1;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;TAGAP;SIRPA;GDI1
prerank,microtubule minus-end binding (GO:0051011),-0.2729604558794843,-0.7147574065449966,0.797752808988764,0.9581489751851523,1.0,3/13,9.67%,TUBGCP4;CEP290;MACF1
prerank,GTPase activator activity (GO:0005096),0.24365487996639917,0.7126405160521587,0.986,0.9824398722059267,1.0,92/313,24.88%,ARHGEF28;ARHGAP10;SGSM2;ARHGAP44;AKAP13;PLCE1;CCDC88C;RABGAP1L;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;RASGRF1;PREB;ARHGAP42;ADAP1;FARP2;ASAP3;TBCK;RASGEF1A;FARP1;MYO9B;FRMD7;FLCN;MYCBP2;SEC23A;OCRL;ARHGAP9;RGL1;HPS4;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;ARHGEF10;TAGAP;RGL2;TBC1D10A;PGAM5;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;HACD3;EEF1B2;MADD;EVI5;SGSM1;EPS8L2;SOS1;ANKRD27;EVI5L;TBC1D13;SRGAP2;ARAP1;RCC1L;ADPRH;TBC1D22B;RP2;TBC1D15;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;RASA1;TIAM1;DENND4B;DENND2A;ARHGAP17;ARRB1;RUNDC1;JUN;NF1;GNB5;CCDC88A;TBC1D8B;TBC1D12;VAV2;DOCK11;BCR;ARHGAP20;STXBP5L;ALS2;TSC2;ITSN1;RGS2
prerank,mRNA 5'-UTR binding (GO:0048027),0.2964362232571627,0.7111099421686106,0.8268292682926829,0.982045966064173,1.0,4/24,15.49%,MRPS11;IGF2BP1;LARP1;RSL1D1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24560133802617712,-0.710008645387332,0.8524590163934426,0.955710506774662,1.0,1/15,2.42%,CCR9
prerank,adenylate cyclase binding (GO:0008179),-0.29002348911561776,-0.7058950292759014,0.82,0.952513386035008,1.0,3/10,12.81%,ADCY5;CAP2;AKAP6
prerank,purinergic nucleotide receptor activity (GO:0001614),0.32654185788651047,0.7058688690152836,0.8365019011406845,0.985547386933659,1.0,1/15,4.28%,P2RX3
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32106810959190274,0.7054170139315383,0.8208955223880597,0.9839618132858238,1.0,6/14,20.31%,EXO5;NDUFS1;ACO2;ETFDH;RSAD1;CIAO3
prerank,DNA replication origin binding (GO:0003688),-0.21515135227009047,-0.6980935998697108,0.9459459459459459,0.9531980449533296,1.0,2/23,3.07%,ORC5;MCM9
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.33206216342157524,0.6955503354169585,0.8452054794520548,0.9925918726526902,1.0,2/12,8.49%,PIK3C2B;PIK3CA
prerank,exonuclease activity (GO:0004527),0.264470506119431,0.6949423020602274,0.8896321070234113,0.991139116788569,1.0,8/46,17.41%,REV3L;EXOSC7;RAD1;FAN1;REXO2;ZC3H12A;EXOSC1;RAD50
prerank,single-stranded DNA helicase activity (GO:0017116),0.3068253520149114,0.6942494145545451,0.8535031847133758,0.9898808638848973,1.0,3/19,15.69%,HELQ;DNA2;RFC4
prerank,metalloexopeptidase activity (GO:0008235),0.2633736500959573,0.6924514449740145,0.8851203501094091,0.9897349148838867,1.0,15/51,25.31%,ANPEP;LNPEP;DPEP1;XPNPEP3;NUDT16;NPEPPS;LAP3;MMP16;METAP2;METAP1;CPZ;METAP1D;MMP15;ZMPSTE24;AGBL1
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2705423753787128,0.6921214247457418,0.8893854748603351,0.9880690122158464,1.0,18/40,35.13%,MEPCE;COMTD1;GAMT;COMT;N6AMT1;ICMT;ASMT;NNMT;SUV39H1;PRMT8;METTL9;THUMPD3;LRTOMT;AS3MT;PRMT7;DNMT3B;FBL;THUMPD2
prerank,phospholipase A2 activity (GO:0004623),0.283648543915378,0.6817998227688855,0.8739290085679314,0.9964418910462348,1.0,3/26,15.33%,PLAAT1;PNPLA8;PLA2G4E
prerank,phospholipase C activity (GO:0004629),0.2905426185905211,0.6803065989196079,0.8727272727272727,0.9958994989071972,1.0,2/25,4.67%,PLCE1;PLCB4
prerank,adenylyltransferase activity (GO:0070566),0.29060129004086566,0.6779184532250818,0.8633004926108374,0.9963145616680641,1.0,5/21,18.36%,TENT4A;SELENOO;PAPOLB;TENT2;TENT4B
prerank,inward rectifier potassium channel activity (GO:0005242),0.28541848051326973,0.6768190716879602,0.8897058823529411,0.9953484767058196,1.0,5/24,23.16%,KCNJ2;KCNJ3;KCNH2;ABCC8;KCNJ11
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.31330709593547573,0.676471333125258,0.8620689655172413,0.9937038519788529,1.0,5/13,21.27%,PIK3C2B;PIK3CA;PIP4K2C;PIP4K2B;PIK3CG
prerank,adenyl ribonucleotide binding (GO:0032559),0.23408705870287905,0.6758882252539803,0.99,0.9922730956449098,1.0,59/291,21.08%,GCLC;TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;PDE10A;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PDE4D;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;GLUD1;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;HCN1;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,acetyltransferase activity (GO:0016407),0.277438991963033,0.6758187941568202,0.8718535469107551,0.9903535632744952,1.0,9/31,22.21%,GNPNAT1;LCAT;KAT2B;NAT8;SAT1;NAA15;NAA50;ACAT1;KAT6B
prerank,Wnt-activated receptor activity (GO:0042813),0.3068257958277016,0.6752932314052182,0.8699080157687253,0.9889312733788519,1.0,3/15,15.34%,PKD1;FZD7;FZD4
prerank,proton transmembrane transporter activity (GO:0015078),0.2654152895303494,0.674542032183941,0.8901472253680635,0.9876245369129814,1.0,7/39,21.20%,CLCN5;SLC11A2;SLC9A1;UQCRQ;ATP6V1B2;UQCRH;UQCR10
prerank,FMN binding (GO:0010181),-0.262090425788186,-0.6742402707651401,0.8350515463917526,0.9686004253251667,1.0,4/11,18.51%,NOS3;NOS1;NDOR1;PPCDC
prerank,retinoid X receptor binding (GO:0046965),0.32146782570984045,0.6741713611765213,0.8481012658227848,0.9859802822400006,1.0,5/11,25.84%,VDR;NRIP1;NSD1;NCOA6;RARG
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.264515740153883,0.6740674268144272,0.8841607565011821,0.984133423033085,1.0,8/35,20.76%,TYW3;FTSJ1;DTWD1;PTRH2;TRPT1;QTRT1;DUS2;QRSL1
prerank,ATP binding (GO:0005524),0.23337534993722836,0.6729051325992234,0.9879759519038076,0.9833725652770919,1.0,54/266,21.08%,TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,channel activity (GO:0015267),0.26271634757278084,0.6722473093437373,0.9150622876557192,0.9820209546721613,1.0,5/41,17.16%,TRPV3;TMEM266;MCUB;TMEM120A;CHRNA7
prerank,death receptor binding (GO:0005123),0.2989073231195227,0.6687819988541137,0.8484076433121019,0.9832956681650238,1.0,3/15,15.90%,TMBIM1;EDA;MADD
prerank,kinase activity (GO:0016301),0.23786244815622512,0.6663439270967431,0.9572301425661914,0.9835996961121678,1.0,26/109,21.27%,PAPSS2;DGKQ;PIK3C2B;MTOR;MVK;CHKB;GK5;PIK3CA;AGK;AKT1;PGM2L1;IRAK1;STK39;PSTK;CERK;PRKD3;PI4KB;PANK1;PI4KA;PMVK;IPPK;PANK3;DCAKD;IP6K1;TRRAP;PIK3CG
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.26946685346398475,0.6648519898704105,0.8871915393654524,0.9830258472793676,1.0,15/27,35.69%,POLR2D;POLR2G;POLR3H;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21;PRIM1;POLR2I;CRCP;POLR2E;POLR2B;POLR2J
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.25853056599907803,0.6637650264694135,0.9251396648044693,0.9820891979682709,1.0,19/44,29.32%,CXXC1;SETD7;WDR5;SETD2;EHMT2;SETD5;PRDM9;KMT2C;SETD1B;KMT2A;N6AMT1;NSD1;EZH2;SETDB1;SETDB2;KMT5A;MEN1;SUV39H1;SETD1A
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.26831457841225026,0.6635984513186903,0.900117508813161,0.9803118792675569,1.0,9/33,20.30%,UBA2;SIAH1;TCERG1;RNF14;AUP1;ARIH2;RNF19A;TOLLIP;ARIH1
prerank,chloride channel activity (GO:0005254),0.2483755030900029,0.6625918789979592,0.9275053304904051,0.9793130036373748,1.0,8/59,19.26%,ANO3;CLCN5;GABRR3;CLCC1;GABRG3;TTYH3;ANO5;GABRG2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3288491454316296,0.6622645700536693,0.8864942528735632,0.977678598715202,1.0,5/10,33.39%,POLD1;DCLRE1A;MGME1;EXO1;TATDN1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.26988545982667234,0.6618975912711318,0.8989169675090253,0.9760984647213278,1.0,10/27,27.36%,POLR2D;POLR2G;POLR3H;TENT2;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.25663689208243373,-0.6597364344303538,0.8838951310861424,0.9741526652104824,1.0,11/12,50.41%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.17072646473628939,-0.6591181122526671,1.0,0.967011617514406,1.0,23/57,26.30%,COX4I1;NDUFA9;NDUFA5;NDUFB4;CYB561A3;UQCR11;NDUFA4;NDUFB10;NDUFB8;NDUFS4;NDUFC1;UQCRFS1;NDUFA10;CYBRD1;NDUFA6;NDUFS2;COX5A;NDUFS8;NDUFA12;NDUFA8;NDUFS6;NDUFS7;NDUFA4L2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.27724480651214445,0.6572459989070585,0.894927536231884,0.9781414467310428,1.0,7/24,20.19%,NME2;PMVK;CMPK2;NME1;AK8;AK9;IP6K1
prerank,NAD binding (GO:0051287),0.27144857753515705,0.6566207493656349,0.9046454767726161,0.9767192624490594,1.0,9/26,21.42%,SIRT2;ZC3HAV1;CRYZ;HSD17B8;GLUD1;NUDT6;BDH2;CTBP1;UXS1
prerank,diacylglycerol kinase activity (GO:0004143),0.316513809522571,0.6496509398640639,0.8908594815825375,0.9805613028297709,1.0,2/11,9.21%,DGKQ;AGK
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25723237523931247,0.6476627549166366,0.9135514018691588,0.9802999483288951,1.0,4/34,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,DNA secondary structure binding (GO:0000217),0.2673392200357915,0.6455935047673436,0.9118683901292597,0.9801060306974287,1.0,12/31,28.97%,XRCC3;RAD51B;MAPT;HMGB3;ERCC5;BLM;KMT2A;CLSPN;RAD51D;MSH6;MEN1;LIN54
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.30457798023676197,0.6418977828527719,0.8956043956043956,0.9811044000839633,1.0,8/13,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;GABRA1;GLRA2;GABRA5;GLRA1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24078773201371267,0.6332099537887178,0.9409799554565702,0.9858255187343196,1.0,13/49,23.47%,ACP2;PTPRJ;PPP5C;DUSP11;SAMHD1;PGAM5;PHOSPHO2;PPP1CC;SMPD1;ACP3;GDPD3;ACP6;LHPP
prerank,sequence-specific mRNA binding (GO:1990825),-0.24836806427316094,-0.6280780349751973,0.8979591836734694,0.9827622340722098,1.0,10/10,75.19%,SSB;SHFL;TYMS;LIN28A;FMR1;DHX9;ETF1;DHFR;RBM24;LARP6
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.288170416320175,0.6225813138821109,0.9051490514905149,0.9916815571830283,1.0,6/14,29.83%,BLVRB;CRYM;PYCR1;DHFR;NOXRED1;PYCR3
prerank,tRNA methyltransferase activity (GO:0008175),0.2770960825153963,0.6222301108513082,0.9146666666666666,0.9900528701151271,1.0,2/16,8.42%,TYW3;FTSJ1
prerank,carbohydrate kinase activity (GO:0019200),0.3031572022453147,0.6212959306218769,0.9236111111111112,0.9888251745194886,1.0,3/11,18.67%,NAGK;GALK1;GNE
prerank,alpha-actinin binding (GO:0051393),0.26191637108242216,0.6166734602247949,0.9283065512978986,0.9901970797922156,1.0,4/24,13.54%,PDLIM7;PKD2;PDLIM1;PALLD
prerank,histone demethylase activity (GO:0032452),0.2566075605465175,0.6163108710750191,0.9411764705882353,0.9885599039444323,1.0,11/27,28.64%,KDM3B;KDM5C;KDM5B;JMJD1C;FBXL19;KDM2B;KDM4C;KDM3A;JARID2;KDM4B;KDM2A
prerank,endodeoxyribonuclease activity (GO:0004520),0.2636019675539323,0.6139339567186807,0.9157088122605364,0.9883308263333295,1.0,5/20,22.85%,ERCC4;DNA2;RAD50;ERCC5;ERCC1
prerank,voltage-gated ion channel activity (GO:0005244),0.2840665721263697,0.6133198052875033,0.91688654353562,0.9869235319939096,1.0,4/14,19.05%,PKD2;VDAC2;VDAC1;HCN1
prerank,pyridoxal phosphate binding (GO:0030170),0.2592543083105349,0.61057196773301,0.9285714285714286,0.9868809008867641,1.0,8/20,30.21%,ACCS;PSAT1;PYGB;GLDC;SRR;CTH;PNPO;PLPBP
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.2317203849613277,-0.6080441722795241,0.9214285714285714,0.9877611735531792,1.0,6/12,26.74%,GABRG1;GABRB3;GABRA4;GABRE;GABRB2;GABRA2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.30519648878849087,0.6079028383766687,0.9177126917712691,0.9868105516547762,1.0,5/10,31.20%,GLCE;GNE;GALM;DSEL;GALE
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.27636310841886913,0.603691827806172,0.9183937823834197,0.9876383356021002,1.0,4/15,17.63%,HS2ST1;HS3ST6;HS3ST5;NDST2
prerank,NAD+ binding (GO:0070403),0.2869942319377583,0.601223157547789,0.9288762446657184,0.9872779755291148,1.0,4/12,21.42%,SIRT2;ZC3HAV1;GLUD1;UXS1
prerank,5'-nucleotidase activity (GO:0008253),0.2851786954252202,0.5958093037735478,0.9105691056910569,0.9887560174539539,1.0,3/13,21.18%,NT5M;ACP3;NT5DC2
prerank,cation transmembrane transporter activity (GO:0008324),0.22670995701049346,0.5920670406669296,0.9590254706533776,0.9891493871864765,1.0,11/48,25.71%,SLC1A5;SFXN1;SLC7A3;SLC15A4;SLC38A1;SLC25A15;SLC8B1;SLC38A9;SLC25A2;SLC36A4;SFXN2
prerank,ankyrin binding (GO:0030506),0.25700329155738744,0.5880835019103821,0.9377431906614786,0.9894547485818193,1.0,6/19,25.91%,SPTBN1;KCTD6;PLEC;SPTBN4;KCNJ11;NRCAM
prerank,neuropeptide receptor binding (GO:0071855),0.26619789050728276,0.5755686951785516,0.9282758620689655,0.9944214554050206,1.0,14/14,73.40%,NMU;SHANK1;AGRP;NTS;PPY;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY
prerank,5'-3' exonuclease activity (GO:0008409),0.26333904181249246,0.5690067382544355,0.9411764705882353,0.9958623445313131,1.0,6/14,32.81%,FAN1;DCLRE1A;TRIR;CPSF3;EXO1;XRN2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.2405719273651547,0.5648027089681898,0.9691358024691358,0.9959576125512284,1.0,6/22,27.79%,CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,symporter activity (GO:0015293),0.27853506098909114,0.5647161589215525,0.9253521126760563,0.9941427209547639,1.0,1/10,11.12%,SLC4A4
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.27288179598410567,0.5633820195771696,0.9467787114845938,0.9928398493940213,1.0,4/11,26.34%,STUB1;AMFR;UBE2K;PRPF19
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.27074837927216616,0.5616220876233771,0.9482758620689655,0.9918640776299771,1.0,1/11,8.04%,HMCES
prerank,GABA receptor binding (GO:0050811),0.27437120168604684,0.5578783694109384,0.9289772727272727,0.9917788220925878,1.0,1/11,6.69%,TRAK2
prerank,kinesin binding (GO:0019894),0.22412079781976385,0.5487495119191674,0.965352449223417,0.994057656692237,1.0,11/27,31.69%,TOR1A;ARHGEF10;ATCAY;CROCC;RAB29;KIFAP3;SPAG9;MAPK8IP3;PLEKHM2;KLC2;KIF1B
prerank,protein phosphatase activator activity (GO:0072542),0.25485879309094583,0.5442699818583959,0.9660130718954248,0.9939487638298476,1.0,3/13,17.06%,B3GAT3;CALM2;PPP2R5B
prerank,tumor necrosis factor receptor binding (GO:0005164),0.24746599902556488,0.5373709019381085,0.9622905027932961,0.9947132668345839,1.0,4/12,23.69%,TRAF3;TRAF4;TRAF5;TRAP1
prerank,GABA-A receptor activity (GO:0004890),0.2382289823682146,0.5340375233843173,0.9672346002621232,0.9941020224732815,1.0,3/18,19.26%,GABRR3;GABRG3;GABRG2
prerank,Notch binding (GO:0005112),0.22022819007852318,0.5175379171030309,0.9702970297029703,0.9976151291240773,1.0,5/22,23.82%,CUL3;JAG1;NCOR2;KCTD10;CCN3
prerank,ligand-gated anion channel activity (GO:0099095),0.23071101898059665,0.5149530069214392,0.9675745784695201,0.9965280643263238,1.0,9/17,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;CFTR;GABRA1;GLRA2;GABRA5;GLRA1
prerank,vitamin D receptor binding (GO:0042809),0.2407049152041058,0.51488761355751,0.9757738896366084,0.994723660470269,1.0,3/14,21.58%,MED24;MED13;THRAP3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.25401023489782915,0.5118623966469225,0.9626972740315638,0.9938105791712748,1.0,5/10,32.99%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.16549246575957277,-0.5102722712639445,0.9893617021276596,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.16549246575957277,-0.5102722712639445,0.9893617021276596,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.16549246575957277,-0.5102722712639445,0.9893617021276596,1.0,1.0,12/22,38.94%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,histone methyltransferase binding (GO:1990226),0.2475825317335452,0.5096779982619528,0.9584487534626038,0.992639798617034,1.0,5/11,34.41%,PHF1;LCOR;NOP56;WIZ;HSP90AB1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.19871477120398873,0.4990031752042226,0.9907514450867052,0.9918482006987186,1.0,9/34,27.22%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.19871477120398873,0.4990031752042226,0.9907514450867052,0.9918482006987186,1.0,9/34,27.22%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.1706643224915233,-0.48425773924582066,0.9779735682819384,1.0,1.0,16/16,82.96%,CD38;TDG;NEIL1;NEIL3;NTHL1;NEIL2;BST1;DNPH1;RPS3;OARD1;MACROD1;ADPRS;SMUG1;MACROD2;ADPRH;SARM1
prerank,endopeptidase activator activity (GO:0061133),0.24029400552679261,0.48397361780308734,0.98005698005698,0.9934842266143783,1.0,1/10,8.48%,ADRM1
prerank,neuropeptide receptor activity (GO:0008188),-0.13724627662917113,-0.4587007354536305,1.0,0.9970450255274749,1.0,29/29,86.31%,TACR1;TACR3;OPRM1;GALR1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;NPY1R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL;HCRTR2;TACR2;MCHR1;SSTR4;SSTR5;GALR3;GALR2;SORCS2;NPSR1;SORCS3;SORCS1;GPR37
prerank,MHC class I protein binding (GO:0042288),0.21251179805796178,0.45843934610920906,0.9919137466307277,0.9961526612057429,1.0,4/13,28.84%,ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,GABA receptor activity (GO:0016917),0.1962331071338804,0.45100174471677307,0.9883870967741936,0.9953035571362523,1.0,3/21,19.26%,GABRR3;GABRG3;GABRG2
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.18685251459785263,0.41043988992047054,0.9946595460614153,0.9973578519017631,1.0,15/15,81.33%,PLA2G4E;PLA2G12A;PLA2G1B;PLA2G4D;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F;PLA2G4C
